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INTRODUCTION 
 
 
Translational control in cancer 
 
Proteins are the most important molecules for life processes as they catalyze 
most of the reactions on which life depends and they serve numerous 
structural, transport and regulatory roles in all organisms. 
Accordingly, a large proportion of the cell’s resources is devoted to 
translation, the process by which the mRNAs are “transformed” in proteins. 
Because of its importance, translation is closely monitored and regulated(1). 
Particularly, translational control has an important role in pathways involving 
cell proliferation and growth, cellular responses to stress such as hypoxia and 
nutrient deprivation, and stimulation by mitogenic signals(1). As a 
consequence translational control is emerging as an important component of 
cancer etiology. It has been known for more than 100 years that nucleoli, the 
sites of rRNA synthesis and ribosome assembly, are considerably enlarged 
and more numerous in highly transformed cells(2). But, in general the 
connections between increased rates of protein synthesis and cell 
proliferation was recognized in the 1970s. For example, engineered reduction 
of protein synthesis by half is sufficient to drive cells into the quiescent G0 
resting phase of the cell cycle, in normal but not in transformed cells causing 
growth arrest(3). Changes in translation associated with cancer development 
and progression observed involve alterations of the expression of eukaryotic 
initiation factors (such as eIF4E, eIF2α, eIF4G and eIF3), of translation 
regulatory factors (such as 4E-BP that blocks eIF4E function and therefore 
cap-dependent mRNA translation), as well as ribosomes and alterations of 
the signalling pathways that activate the mRNA translation (primarily the 
PI3K-AKT-mTOR and Ras pathways)(4-11). These changes are manifested in 
a variety of ways, including up-regulation of global protein synthesis, 
increased translation of individual mRNAs, and selective translation of 
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antiapoptotic, proangiogenic, proproliferative, and hypoxia-mediated 
mRNAs. Other transformation-associated changes in translation are directed 
to uncoupling of signal transduction and translational control pathways that 
suppress translation during physiological stresses and impair cell growth (cell 
mass) and cellular proliferation (cell division)(1). 
In a multistep process as the protein synthesis is, the control can be driven at 
different levels: initiation, elongation and termination. Even if there are well 
documented cases of translation control during the late stages such as the 
elongation phase, the principal control regards the initiation step.  This 
observation is in line with the biological principle that is more efficient to 
govern a pathway at its outset than to interrupt it in midstream and have the 
deal with accumulation of intermediates and recycling. So that initiation is 
the step that limits the speed of the translational process. That’s why its 
impairment is deeply involved in cancer. Therefore, I will focus on it during 
my discussion. 
 
 
 
 
 
 
Cap-dependent mRNA translation initiation and cancer 
 
In the eukaryotes, translation initiation is the step that leads the assembly of 
an elongation-competent 80S ribosome from small (40S) and large (60S) 
ribosomal subunits. The “standard” translation initiation requires separated 
40S and 60S, involves at least 12 eukaryotic initiation factors (eIFs) and the 
binding and the hydrolysis of GTP. Indeed, most important is the recognition 
of the  m7G[5’]ppp[5’]N cap ( m7G-cap, where N is any nucleotide) at the 
5’-terminal of the mRNAs. For that reason the canonical translation initiation 
is called cap-dependent(1). 
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Cap-dependent translation initiation: an overview 
 
The cap-initiation process consists of a series of steps that can be 
summarized as follow(1): 
- Selection of an aminoacylated initiator methionyl-transfer RNA 
(Met-tRNAi) from a pool of tRNAs by the binding with the 
eukaryotic initiation factor 2 (eIF2) to form a ternary complex 
eIF2/GTP/Met-tRNAi. The ternary complex together with other 
initiation factors (eIF3, eIF1 and eIF1A) binds the 40S to form a 
new complex called 43S ribosome pre-initiation complex; 
- Recruitment of the 43S ribosome complex on the m7G[5’]ppp[5’]N 
cap at the 5’-terminal of the mRNAs. The association of the 43S 
ribosome complex with the cap is mediated by the cap-binding 
complex eIF4F. eIF4F is composed of three IFs that are eIF4G, 
eIF4E and eIF4A. Also associated with eIF4F and involved in the 
initiation are several initiation factors such as eIF3 and other 
mRNA binding protein like the polyA-tail binding protein (PABP); 
- Ribosomal scanning on the mRNA starting from the 5’ untranslated 
region (UTR) directed to the first initiation AUG codon (5’-3’ 
direction) to form the 48S complex; 
- Recognition of the initiation codon due to its complementarity with 
the anticodon of the Met-tRNAi; 
- Release of the initiation factors from the 48S surface to permit the 
binding of the 60S and the formation of the elongation-competent 
complex 80S. This step involves the presence of some many others 
initiation factors like eIF5 and eIF5B. 
Cap-dependent translation initiation is summarized in Figure 1. 
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Figure 1. Schematic representation of the cap-dependent translation initation(1). The canonical pathway 
of eukaryotic translation initiation can be divived into eight steps. These steps result in the formation of an 
elongation competent 80S ribosomal complex. 
 
Most important, each step of the cap-dependent translation initiation 
described is well regulated in normal eukaryotic cells both by regulation of 
the activity or the level of expression of the initiation factors and by the 
regulation of the major pathways involved in the activation of protein 
synthesis. An alteration of such regulatory mechanisms can be implicated in 
transformation and tumour progression. An overview of the steps of the cap-
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translation initiation that can be involved in cancer is presented in Figure 2 
and each step will be described in the next paragraph. 
 
 
Figure 2. Eukaryotic cap-dependent mRNAs translation steps and cancer(52). The major regulated steps 
for the cap-translation initiation are shown. eIF4F formation is rate-limiting for initiation, and increased 
abundance of its components occurs in many cancers. The different expression of one or more subunits of 
eIF3 complex can interfere with the reclruitment of the 43S ribosome complex in cancer. The regulation of 
protein synthesis by eIF2α phosphorylation has a complex role in cancer too.  
 
 
Alteration of cap-dependent translation initiation in cancer 
 
As described before, the first step of translation initiation is the formation of 
the 43S ribosome initiation complex. Particularly the activity of this complex 
is regulated by the phosphorylation state of eIF2(12). eIF2 is an eterotrimeric 
complex composed of α, β and γ subunits capable of binding  GTP. Only 
when eIF2 is bound to the GTP (a process mediated by eIF2B), the ternary 
complex eIF2/GTP/Met-tRNAi can recruit the 40S to form the 43S ribosome 
initiation complex. When the eIF2α subunit is phosphorylated, eIF2 cannot 
recycle GDP in GTP and the protein synthesis is inhibited (Figure 3).  
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Figure 3. Eukaryotic initiation factor 2 and the phosphorilation of its α  subunit(13). eIF2α is a subunit 
of eIF2 (together with eIF2β and eIF2γ) that is part of the ternary complex. Phosphorylation of eIF2α 
inhibits the GDP–GTP exchange by reducing the dissociation rate of eIF2B. Ultimately, this results in the 
inhibition of global translation. 
 
 
The phosphorylation of the α subunit is mediated by a related group of 
protein kinases in response to various physiological stresses (e.g. hypoxia) 
that block protein synthesis. These kinases are: heme-regulated inhibitor 
kinase (HRI or EIF2AK1) that is active in erythroid cells under condition of 
heme deprivation, protein kinase RNA (PKR or EIF2AK2) that is active in 
response to viral infection, PKR-like endoplasmatic reticulum (PERK or 
EIF2AK3) that is active in response to the presence of unfolding proteins in 
the endoplasmatic reticulum and general control non-derepressable-2 (GCN2 
or EIF2AK4) that is active in response to nutrient deprivation. Instead the de-
phosphorylation is catalized by GADD34 (Figure 2). 
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It’s now well known that a deregulation of eIF2α subunit phosphorylation 
can be involved both in the stimulation and in the prevention on cancer 
probably accordingly with this context. In some studies in mice 
overexpression of a mutant form of eIF2α that cannot be phosphorylated or 
of a dominant interfering form of PKR, promotes tumorigenesis(14,15). 
Accordingly, increased levels of eIF2α subunits (demonstrated by 
immunohystochemical experiment) are found in colon carcinoma and 
adenoma, malignant melanoma, bronchioloalveolar carcinomas and more 
aggressive brain cancers(16,17,18) . 
In contrast to these results, elevated level of active PKR (which oppose eIF2 
function and was suggested to have tumour suppressor activity) are found in 
melanoma lymph node metastases and colon carcinomas(19). In breast cancer 
low levels of PKR are reported in preneoplastic breast lesions, whereas 
higher levels are reported in the more aggressive invasive ductal 
carcinomas(20,21). One explanation to this could be that the phosphorylation of 
eIF2α can occur in the early stages of the disease as a response to severe 
stress (e.g. hypoxia) to reduce protein synthesis and permit cancer cell 
surviving (22). Indeed, even if phosphorylation of eIF2α leads to decrease the 
global translation rates, translation of some mRNAs like growth factors (such 
as Vascular Endothelial Growth Factor) or anti-apoptotic factors (like X-
chromosome-linked Inhibitor of Apoptosis) continues or is even enhanced 
since their translation is controlled by alternative kinds of translation called 
cap-independent. This kind of translation could be mediated by special 
secondary structures on the 5’UTR of some mRNAs called Internal 
Ribosome Entry site (IRES). I’ll discuss about this kind of translation later in 
this thesis (23). It’s clear that more research needs to be done to understand the 
role of eIF2 phosphorylation in human’s tumours.  
 
The second step of translation initiation is the recruitment of the 43S  
ribosome pre-initiation complex on the mRNA that is mediated first by the 
presence on the mRNA of the eIF4F cap-binding initiation complex and 
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second by the involvement of another important initiation factor complex 
eIF3. eIF4F is a multiprotein complex formed from 25-, 46- and 220-kDa 
subunits, called eIF4E, eIF4A, and eIF4G, respectively. eIF4E  is a cap-
binding protein, eIF4A is  an ATP-dependent helicase (the activity of which 
is stimulated by the RNA binding protein eIF4B) and eIF4G  is a large 
scaffolding protein(1) (Figure 4).  
 
 
 
 
 
Figure 4. eIF4F complex(24). The figure shows the components of eIF4F complex and the its binding on the 
m7G[5’]ppp[5’]N cap at the 5’-terminal untransalted region of the mRNAs. 
 
eIF4E is responsible for binding the m7Gcap found on all eukaryotic 
mRNAs. In 1990 was published the first report implicating eIF4E in 
oncogenesis(25). That report clearly indicated that the overexpression of eIF4E 
promotes transformation of immortalized murine NIH-3T3 cells in vitro and 
confer them solid-tumor growth properties if subcutaneously transplanted in 
nude mouse models. The transformation of immortalized cells could be 
attributed to the direct overexpression of eIF4E as antisense inhibition of it 
profoundly represses tumor growth and malignancy. Since these reports in 
the early 1990s, numerous articles have now substantially enhanced our 
understanding of the role for eIF4E in malignancy. Particularly, 
overexpression of eIF4E has been demonstrated in colorectal, lung, head and 
neck, thyroid, bladder, skin and breast cancers as well as in non-Hodgking’s 
lymphomas(26,27). Disputing the correlation between overexpression and 
prognosis or survival, eIF4E expression is strongly associated with worse 
clinical outcome and decreased survival. The role of eIF4E in transformation 
and cancer progression seem not to be due by the global increase of 
translation but probably depends on the  selectively increased translation of a 
subset of mRNAs containing structured 5’UTR(28,29). These mRNAs encode 
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proteins with notable functions in all aspects of malignancy, including 
angiogenesis (vascular endothelial growth factor A (VEGFA) and fibroblast 
growth factor 2 (FGF2)), cell cycle progression (c-MYC) and survival 
(survivin). Interestingly, most mRNAs that are characterized by short, 
unstructured 5’UTRs (e.g., h-actin) are largely unaffected by changes in 
eIF4E expression(28,29). Recently most importance is given not only on eIF4E 
abundance but also to its availability and/or activity. We know, in fact, that 
eIF4E availability and/or activity are regulated by its phosphorylation at Ser 
209 and by the eIF4E inhibitory binding proteins (4E-BPs). Both of them 
seem to be important in the oncogenesis.  
eIF4E phosphorylation is mediated by its binding to eIF4G which brings it 
into proximity with the MNK1 and MNK2 kinases. The phosphorylation of 
eIF4E stimulates translation initiation in vitro. Mitogen-enhanced eIF4E 
phosphorylation usually correlates with increased protein synthesis(30) and 
phosphorylation increases the binding of eIF4E to capped mRNA and to 
eIF4G(31). The location of Ser 209 adjacent to the cap-binding pocket is 
consistent with an effect of phosphorylation on mRNA binding (Figure 5).  
 
 
 
 
 
 
 
 
 
Figure 5. eIF4E phosphorylation(32). Both MNK1 and eIF4E interact with eIF4G, bringing the two proteins in 
close proximity, resulting in more efficient eIF4E phosphorylation. 
 
Overexpression of phospo-eIF4E is found in 63% of human cancer of 
different origin (lung, colorectal, stomach, liver, kidney, breast, ovary, head 
and neck and brain) compared with 30% of adiacent non-cancer tissues(33). 
Indeed p-eIF4E expression seems to be significantly higher in the early 
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stages of disease than in the advanced stages in certain types of cancers (e.g., 
colorectal and gastric cancers). Thus, it seems that p-eIF4E may play an 
important role in the earlier stages of malignant transformation than in the 
late stage of these types of cancers(33).  
As mentioned eIF4E availability is due to the presence of 4E-Binding 
proteins, the most important of which is 4E-BP1. When 4E-BP1 is 
hypophosporilated is able to bind the initiation factor eIF4E blocking his link 
with the other components of the initiation complex. Instead when, thanks to 
the activation of the mTOR pathway, 4E-BP1 is hyperphosphorilated eIF4E 
is reliase and available to form the complex(32) (Figure 6). Less is known 
about 4E-BP1 status on cancer. For example it’s known that in advanced 
prostate cancer(34) and higher-grade breast cancer(35) there are high levels of 
phospho-4E-BP1 which in turns correlates with high amount of available 
eIF4E. On the other hand in some advanced but clinically non-metastatic 
cancers, like the oesophageal one or the locally advanced breast cancer 
(LABC) there is an overexpression of active 4E-BP1 and a consequent 
sequestering of eIF4E(36,37). In this case it’s probably that alternative 
mechanisms of initiation can be favoured. 
 
 
Figure 6. The binding of the 4E-BPs to eIF4E is regulated by phosphorylation(93). Various stimuli 
increase the phosphorylation of the 4E-BPs. Hyperphosphorylated 4E-BPs have a relatively low affinity for 
eIF4E. Conversely, a decrease in 4E-BP phosphorylation increases the affinity of the 4E-BPs for eIF4E.  
 
Little attention is paid, right now, to the other eIF4F components. 
eIF4G, the scaffolding  protein of eIF4F, when overexpressed in NIH-3T3 
cells drives theirs transformation in the absence of eIF4E overexpression(38). 
In inflammatory breast cancer (IBC) is shown an overexpression of eIF4G 
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itself without changes in eIF4E or 4E-BP1(39). That’s why much more than in 
cap-dependent translation seems to have an important role in the so-called 
cap-independent translation. This is not the first time that I’ve mentioned the 
alternative way for translation to initiate and its possible implications in 
cancer and that’s why I will focus on them later. 
 
Once eIF4F is bound to the mRNA another complex is essential to permit the 
interaction with the 43S pre-initiation complex. This complex is eIF3, a 
complex of 10-13 proteins. The roles of eIF3 in cancer can be clarified by 
examining the individual contribution of each subunit(40). The major subunits 
involved in cancer are eIF3a, eIF3b, eIF3c, eIF3h, eIF3f and eIF3e(41). 
Particularly, overexpression of eIF3a is associated with breast, cervical, lung, 
oesophageal and stomach cancer(42-46). Overexpression of eIF3c is associated 
with testicular seminomas and meningiomas(47,48). Overexpression of eIF3h is 
associated with high grade prostate cancer(49). In all these cases the 
overexpression seems to have a double role: promote protein synthesis by 
iperactivating the translation initiation and inhibit the translation of subset of 
mRNA involved in tumour suppressor such as p27 (for eIF3a) or merlin ( for 
eIF3c). On the other hand loss of expression of eIF3f is associated with 
pancreas, breast, ovary, small intestine tumours and melanomas(50) and loss of 
expression of eIF3e is associated with breast and lung carcinomas(51). In the 
first case is known that eIF3f has tumour suppressor properties, instead 
remain unclear the translational mechanisms by which eIF3e can drive 
tumour progression. 
A list of the initiations factors with a description of the cancers in which their 
different expression/regulation is involved is summarize in Table1. 
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Factor 
 
Function  
 
Observed modification Cancer association 
PKR  eIF2α kinase Decreased expression Progression from benign to malignabt HNSCC: 
indolent papillary thyroid carcinomas 
  Increased expression Colon adenocarcinomas and carcinomas aggressive 
IDC and hight grade viral HCC 
eIF2α 
 
Forms an eIF2–GTP–
Met-tRNAi ternary 
complex that binds to 
the 40S subunit, 
thus mediating 
ribosomal recruitment 
of Met-tRNA 
Increased expression Benign and malignant melanomas and colon 
cancers: associated with more aggressive brain 
cancers 
eIF3a Binds 40S subunits, 
eIF1, eIF4G and eIF5; 
stimulates binding of 
eIF2–GTP–Met-tRNAi 
to 40S subunits; 
promotes attachment of 
43S complexes 
to mRNA and 
subsequent scanning; 
and possesses ribosome 
dissociation and 
anti-association 
activities, preventing 
joining of 40S and 60S 
subunits 
Increased expression Breast,cervical, lung, oesophageal and stomach 
cancers 
eIF3c  Increased expression Testicular seminomas; meningiomas 
eIF3h  Increased expression High-grade prostate cancers and gene amplification 
in NSCLC24 
eIF3f  Decreased expression Pancreas, breast, ovary and small intestine tumours; 
gene loss in melanomas 
eIF3e  Decreased expression Breast and lung carcinomas 
eIF4E Binds to the m7GpppG 
5′ terminal ‘cap’ 
structure of mRNA 
Increased expression Correlates with worse clinical outcome and 
decreased survival in breast, head and neck, 
colorectal, lung, prostate, bladder, skin and cervical 
cancers, and lymphomas; correlates with increased 
malignancy in meningiomas, glioblastomas and 
astrocytomas; associated with 
decreased survival in advanced prostate cancers; 
LAEC 
Phospho-eIF4E  Increased phosphorylation In prostate cancer compared with normal tissue; 
correlates with 
anti-apoptotic gene expression in DLBCL and 
Burkitt’s lymphoma;associated with serous 
histological type and better survival in ovarian 
tumours; observed in most human cancers; 
associated with lower stage colorectal, lung and 
gastric cancers; no correlation with malignancy in 
meningiomas, glioblastomas and astrocytomas 
despite eIF4E correlation 
eIF4G Binds eIF4E, eIF4A, 
eIF3, PABP, SLIP1 and 
mRNA and enhances 
the 
helicase activity of 
elF4A 
Increased expression Associated with decreased metastatic progression in 
LABC; associated with IBC and formation of 
metastatic cancer cell emboli; associated with 
increased CCND1 translation in squamous lung 
carcinoma 
4E-BPs Regulates eIF4E 
availability 
Decreased expression Reduced survival in advanced prostate cancers 
  Increased expression Associated with reduced tumour grade in breast 
cancers reduced metastatic progression in LABC, 
and with LAEC 
Phospho-4E-BP1  Increased phosphorilation Decreased survival in advanced prostate cancers; 
higher grade and reduced survival in breast cancers; 
poor differentiation and higher mitotic rates in 
ovarian tumours; LAEC 
Table 1. Translation factors and translation regulatory factor alteration in human cancer. eIFs 
functions and their alterations in cancer are shown.CCND1= cyclin D1; DLBCL= diffuse large B cell 
lymphoma; HCC=hepatocellular carcinoma; HNSCC=head and neck squamous cell carcinoma; IBC, 
=inflammatory breast cancer; IDC,=nvasive ductal carcinoma; LABC=locally advanced breast cancer; 
LAEC= locally advanced oesophageal cancer; NSCLC,=non-small-cell lung cancer.  
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Cap-independent mRNA translation initiation and cancer 
 
For long time the “cap-dependent” or “scanning” mode of initiation was 
considered the only way through which translation of eukaryotic mRNAs 
could be initiated. During the years, it started to be clear that a number of 
cellular physiological and pathological stress responses (such as hypoxia or 
nutrient deprivation) involve inhibition of one or more general translation 
initiation factors, yet the adaptive responses to stress require new protein 
synthesis. Logically, cells need mechanisms that could allow mRNAs 
encoding key regulatory proteins to escape the general inhibition of 
translation. The observation that some cellular mRNAs continue to be 
translated in poliovirus-infected cells after the inhibition of cap-dependent 
initiation (through cleavage of eIF4G by a virally encoded protease) is 
consistent with this hypothesis(53). Indeed mRNAs with very long 5’UTRs or 
containing numerous predicted stem-loop structures or upstream AUG 
codons within their 5’UTRs could be translated with reasonable efficiency, 
despite evidence that such features can significantly reduce translation of 
model mRNAs(54-56). All these observations led the researchers to investigate 
the presence of alternative mechanisms of translation initiation that, in the 
complex, are called as cap-independent translation. Most of the knowledge 
on this matter came from the study made on virus translation initiation.  
Ribosome shunting is an alternate mechanism of translation initiation in 
which ribosomes bind to the mRNA in a normal cap-dependent mode, then 
jump upstream (5'→3') of the initiator AUG codon. It appears less dependent 
on eIF4F than is scanning-mediated initiation, so it may also support 
translation of specific mRNAs under conditions in which eIF4F activity is 
reduced, such as viral infections and heat stress(57) (Figure 7). 
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Figura 7. Ribosome shunting(58). The ribosome shunts over a large segment with extensive secondary 
structure, possibly containing start codons. 
 
For some mRNAs, shunting has been shown to require various mRNA 
elements, some of which are thought to base pair to 18S rRNA. The data 
obtained provide direct evidence that ribosomal shunting can be mediated by 
mRNA-rRNA base pairing, a finding that may have general implications for 
mechanisms of ribosome movement(59). 
Studies of viral gene expression in the late 1980s led to the discovery of an 
alternative mode of translation initiation in eukaryotic cells that allows the 
40S ribosome to be directly recruited to the vicinity of the initiation codon 
bypassing the binding of the cap(60). The mRNA regions required for this 
direct recruitment of the 40S ribosomal subunit are termed Internal Ribosome 
Entry Sites (IRESs) to emphasize that the process is independent of the 5'-
end recognition. It has been shown that specific eukaryotic mRNAs can have 
IRESs too(61) and that viral and cellular IRES-driven translation initiation is 
typically utilized when cap-dependent initiation is compromised (Figure 8). 
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Figura 8. IRES-mediated translation initiation(61). This translation initiation mechanism is generally 
independent of the recognition of the 5’cap-mRNA end and involves direct recruitment of the 40 S ribosome 
to the vicinity of the initiation codon (directed by an IRES element). The 40 S recruitment is assumed to be 
accompanied by the simultaneous recognition of the initiation codon. 
 
As might be thus expected, IRES-driven translation has a generally reduced 
requirement for canonical translation initiation factors, particularly members 
of the eIF4F complex (initiation factors eIF4E and eIF4G). Moreover, in 
certain “extreme” cases, initiation can proceed without involvement of any of 
the canonical initiation factors(62). In addition, a number of proteins have been 
identified that are capable of modulating (typically enhancing) internal 
initiation called IRES trans-acting factors (ITAFs)(63). Because this is the 
most well studied alternative (cap-independent) mechanism for translation 
initiation I’ll focus on that deeply later. 
Finally, in the discussion the alternative way of translation initiation some 
new updates might be mentioned. It seems to be reasonable that the cap-
independent translation does not need to be necessary directed by an IRES 
but it can be 5′ end- and scanning-dependent(64). Some studies, using 
transfection of cells with capped and uncapped reporter mRNAs, found that 
the contribution of the cap is not similar for various 5′ UTRs of cellular 
mRNAs, though none of the tested cellular 5′ UTRs had an IRES(65). Some of 
them were stimulated by the 5′ cap much stronger than the other. Notably, 
there was no correlation between the magnitude of the stimulation effect and 
the length or the overall stability of the 5′ UTR secondary structure. This 
means that even in the absence of the eIF4E-cap interaction, the translational 
machinery is able to recognize the 5′ end, bind there and then scan to the 3′ 
end in a search for the initiation codon(65-68). All these works clearly 
demonstrated that although the stimulation effect was cap-independent, it still 
required 5′ end-dependent ribosome binding. Therefore, there must be some 
elements within eukaryotic mRNAs that can promote a cap-independent 
translation initiation but are not truly IRESs. Some indications about the 
mechanisms come again from virus studies. 
The mRNAs of a large portion of all plant viruses lack the m7GpppN-cap 
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structure and they employ a strategy alternative to the internal ribosome 
entry. They use special elements termed Cap Independent Translation 
Enhancers (CITE)(69-71). The majority of CITEs is located in 3′ UTRs (so 
called 3′ CITEs). CITE is thought to recruit components of translational 
apparatus (such as eIF4E or eIF4G) and then to deliver it to the 5′ end of 
mRNA through long distance base pairing between 5′ and 3′ UTRs (Figure 
9).  
 
 
 
Figure 9. 3′ CITE-assisted initiation(64). 3′ CITEs are shown in violet color. In this particular case, eIF4E 
and eIF4G bind by means of CITEs to the 3′ UTR of an mRNA. A long distance interaction of stem-loop 
structures results in circularization of the mRNA and positioning of the scanning machinery near its 5′ end. 
 
 
It should be noted that the initiation on the 5′ UTR of these mRNAs directed 
by the 3′ CITE is cap-independent, but 5′ end dependent and requires 
scanning to locate the authentic initiator codon. Moreover, when placed in 5’ 
UTRs, CITEs can direct cap-independent translation too(72). Finally is 
demonstrated that the CITEs don’t work as IRES when placed between two 
cistrons(70). Thus, the CITE: a) can recruit eIF4F, b) can stimulate a cap-
independent, but 5′ end-dependent translation when placed at the 5′ end of 
mRNA, c) cannot direct an internal initiation. This allows hypothesizing that 
some kind of CITE-like elements may exist within 5′ UTRs of mammalian 
mRNAs (5′ CITEs) as illustrated in Figure 10.  
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Figure 10. 5′ CITE assisted initiation initiation(64). In this case, a CITE is located within the 5′ UTR and is 
capable of additional, presumably rather weak interactions with initiation factors of the scanning machinery. 
Although the recognition of the cap by eIF4E still plays a major role in the mRNA recruitment, the primary 
binding of the mRNA is still possible in the absence of this interaction, solely due to some interactions of 
key initiation factors (or the 40S ribosomal subunit itself) with 5′ CITEs. 
 
 
They allow these mRNAs to be preferentially translated under conditions 
when translation of “canonical” cap-dependent mRNAs are strongly 
inhibited. It could be also possible that such translational enhancer elements 
can recruit dedicated ribosome binding proteins (RBPs)(73). Although it is not 
yet clear how many RBPs might similarly bridge interactions between 
cellular 5-UTRs and the translation machinery, even the relatively small 
yeast genome is predicted to encode 300 RBPs (exclusive of ribosomal 
proteins), each with a specific set of RNA targets(73). 
 
 
IRES-mediated translation initiation 
 
Under relevant conditions which downregulate cap-dependent mRNA 
translation (for example, amino acid starvation, mitosis, hypoxia and 
apoptosis), the expression of key genes that are involved in cell proliferation, 
differentiation and apoptosis is needed. As mentioned above, translation of 
these mRNAs occurs by “alternative” translation initiation mechanisms the 
most common and studied of which is known as IRES mediated-
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translation(74). Little is known about the exact mechanisms by which initiation 
by the IRES occurs. Translation of viral and cellular mRNAs IRESs has 
received increased attention during recent years due to its emerging 
significance for many physiological and pathological stress conditions. The 
existence of an IRES within the 5’UTR of a viral or cellular mRNA is 
verified by the use of the bicistronic assay(1). In the bicistonic assay, the 
bicistronic mRNA is engineered to contain two cistrons (or open reading 
frames ORFs) with the putative IRES element inserted between them. The 
first cistron is translated by the cap-dependent scanning mechanism, whereas 
translation of the second cistron does not happen unless internal initiation at 
the IRES element occurs. The commonly used vector for the bicistronic assay 
is the pRF vector which contain the Renilla and the Firefly luciferases coding 
regions as the first and the second cistrons as shown in Figure 11. Of course 
other reporter such as the chloramphenicol acetyltransferase (CAT) can be 
used. 
 
 
 
 
 
Figure 11. Typical bicistronic reporter plasmid used for IRES assays(73). A strong promoter such as 
SV40 drives expression of a bicistronic mRNA. Renilla luciferase activity reports the level of cap-dependent 
initiation in the experiment. Firefly luciferase activity is very low unless the intercistronic region contains an 
IRES. 
 
 Viral-IRESs 
 
Viruses use the components of the host cell for gene expression and 
replication. Soon after infection, the host cell often tends to limit viral 
production and replication by shutting-off global translation. This regulatory 
mechanism generally targets events from the initiation phase because it is the 
rate-limiting step that determines overall protein production for most 
mRNAs. Many viral genomes have evolved to bypass this general inhibition 
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of translation by developing mechanisms of initiation independent of the 
classical recognition of an m7G cap structure at the 5′ end of the mRNA. 
These mechanisms imply the utilization IRESs which can promote 5′ end 
independent initiation(60). The existence of internal ribosome entry in viruses 
was proven in two laboratories simultaneously, by Sonenberg (MacGill, 
Canada) and Wimmer (Stony Brook, USA)(64). In spite of a large variety of 
structures of viral IRESs, there is one property of well-studied viral IRES 
elements which is common to all of them, regardless of their organization 
and mechanism of functioning. As clear from the data described above, they 
all have at least one specific site within their structure with a high affinity to 
a key translational component. These highly specific and strong binding sites 
for key ribosome recruiting components or ribosome itself are real hallmarks 
of viral IRESs. Their existence helps to understand how and why 40S 
ribosomes are directed to a defined internal region of the 5′ UTR of an 
mRNA rather than to the 5′ end or any other sequence within this mRNA. 
The existence of specific and strong binding sites for initiation  factors or 
ribosomes within 5′ UTRs is a mandatory but not the only specific property 
of true viral IRES-elements. Another property is a highly specific secondary 
and tertiary structure of these IRES-elements that are probably needed for the 
sequences in vicinity of the initiation codon to be accommodated in the 
ribosome mRNA-binding channel. The mechanism of this accommodation is 
still poorly understood. Probably, it involves a change of conformation of the 
small ribosomal subunit(64). Viruses IRESs are divided into four major 
structural groups, epitomized by poliovirus (PV; Type 1), 
encephalomyocarditis virus (EMCV; Type 2), hepatitis C virus (HCV; Type 
3) and cricket paralysis virus (CrPV; Type 4)(75). The Type 1 and 2 IRESs 
belong to the picornaviridae mRNAs, the Type 3 IRESs belong to the 
Flaviviridae mRNAs and the Type 4 IRESs belong to the Dicistroviridae 
mRNAs. 
 
All picornaviruses share a long and structured 5′ UTR (600 to 1200 nt 
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depending of the virus) containing multiple upstream AUG triplets that are 
never used to start translation. As mentioned before, based on biochemical, 
structural and phylogenetic studies the picornaviral IRESes are divided into 
two major groups: type I IRESes are found in the mRNAs of enteroviruses 
(i.e. PV) and rhinoviruses and type II are found in the mRNAs of 
aphthoviruses (i.e. FMDV), and cardioviruses (i.e. EMCV)(60).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Schematic representation of the two picornaviral IRESs(60). (A) Structures of the 5′UTR of 
PV (type I IRES). The body of the IRES within the 5′UTR is underlined in green. The binding sites for the 
viral proteins PCBP and 3CD on the clover leaf structure are indicated. The ribosome enters the RNA at 
nucleotide 586 just after the oligopyrimidine tract and then scan down until it reaches the authentic initiation 
site located at position 743. (B) Structures of the 5′UTR of EMCV (type II IRES). The core of the IRES 
within the 5′UTR is underlined in green. The binding site for PTB and eI4G are indicated. The ribosome 
lands and initiates at the AUG located at the end of the polypyrimidine tract. 
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All picornaviral IRESes share some characteristics in common which is the 
presence of a GNRA motif in the central domain which adopts a tetraloop  
conformation and a small polypyrimidine rich tract that lies about 20 to 25 
nucleotides upstream of an AUG triplet (Figure 12). In type I IRESes this 
AUG codon is not utilized to start translation and the ribosome has to scan 
some 100 to 150 nucleotide downstream to initiate protein synthesis at the 
next AUG (Figure 12). Studies on EMCV type II IRESes have shown that the 
distance between the oligopyrimidine tract and the initiator AUG is critical 
and that the 40S ribosome seems to be loaded directly, or, at the immediate 
vicinity of this AUG without any scanning process(60). Experiments using a 
reconstituted translation assay in which all the components required for 
translation initiation (initiation factors, amino acids, ribosomes, mRNA and 
tRNAs) are added sequentially to form a preinitiation complex, demonstrate 
that virtually all of the canonical translation factors were needed to recruit the 
40S subunit, on the EMCV IRES, with the exception of eIF4E and the 
aminoterminal of eIF4G. The initiation factor eIF4G also appears to be a key 
player in the recruitment of the 43S complex onto the IRES sequence. It has 
been shown that eIF4G has the ability to directly contact the IRES sequence 
of EMCV at the J–K domain and the stem–loop V of PV in association with 
eIF4B (see Figure 12). If some picornaviral IRESes such as EMCV are able 
to efficiently drive translation in the rabbit reticulocytes lysate (RRL) with 
the sole set of canonical initiation factors, this is clearly not the case for 
members of the polio-/rhino-virus genera. Translation of these type I IRESes 
in the RRL results in a very low yield of protein production. Interestingly, 
such profile can be corrected by supplementation of the reticulocyte lysate 
with HeLa cell extracts(60) suggesting that some cellular factors that are 
present in HeLa but absent from the RRL are needed for ribosomal entry. 
These factors were called IRES trans-acting factors (ITAFs). A schematic 
representation of the Type I and Type II IRES-mediated translation is shown 
in Figure 13. 
 
Introduction 
 
                                                                             
 22 
 
 
Figure 13. Type I and II IRES-mediated translation(76). Initiation on type 1 and type 2 IRESs involves 
their specific binding to eIF4G, which is enhanced by eIF4A. The eIF4G–eIF4A complex recruits 43S 
complexes to type 1 and type 2 IRESs without the involvement of eIF4E. Initiation on type I IRESs also 
requires IRES trans-acting factors (ITAFs)-RNA-binding proteins that are thought to stabilize the optimal 
three-dimensional IRES conformation. 
 
 
The Hepatitis C Virus (HCV), the most representative member of the 
Flaviviridae, was shown to contain an IRES in its 5′ UTR. HCV IRES is 
composed of a 5′ UTR of 341 nt long (up to the AUG codon) and folds into 
four major structural domains numbered I to IV(60). An interesting feature of 
the HCV IRES is the fact that the sequences required for IRES activity are 
located between domains II and III and IV and extend beyond to the AUG 
codon on the first 30 nucleotides of the ORF. Domain I appears to be 
dispensable for translation activity. Secondary structures of the HCV IRES 
are summarized in Figure 14. Domain II is a 75 nt long hairpin structure with 
3 internal and a terminal loop that enhances significantly IRES activity 
although it is not absolutely necessary. Domain III is the largest RNA 
structure and comprises several helices and hairpins named IIIa to IIIf. 
Domains IIIa– IIIc and IIIe–IIIf form a three-way helical junction with the 
IIIf stem– loop being part of the pseudoknot that is essential for ribosomal 
recruitment (Figure 14).  
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The mechanism of ribosomal recruitment onto the HCV IRES is quite 
different from that described for the picornaviruses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Schematic representation of the secondary structure of the 5’UTR of HCV(60). The IRES is 
composed of domains II–III–IV whereas domain I is dispensable for IRES activity. The AUG initiation 
codon is part of the loop of domain IV extending. 
 
The assembly of the 48S initiation complex is independent of eIF4A, eIF4B, 
and eIF4F. In fact, a crude 40S ribosomal subunit can directly bind to stem–
loops IIId or IIIe of the HCV IRES, and intermolecular contact zones have 
been reported on most of the IRES sequence(60). These contacts are due to 
interactions between RNA motifs from the IRES and ribosomal proteins that 
constitute the 40S subunit. As a result of this interaction, the positioning of 
the HCV IRES on the surface of the 40S ribosomal subunit induces a 
conformational change that clamps the mRNA and positions the AUG codon 
in the P site of the ribosome with no need for ribosomal scanning. 
Furthermore the IRES can also directly bind to the initiation factor eIF3 via 
loops IIIa and IIIb and the junction domain IIIabc. This interaction is 
essential for the recruitment of the eIF2–tRNAi Met ternary complex and the 
initiation of translation (Figure 15). Thus, direct interaction between the 
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IRES and the 43S ribosome results in the correct positioning of the initiator 
AUG in its P site, in a “prokaryotic mode”; after recruitment of the ternary 
complex stabilized by eIF3, the hydrolysis of eIF2-bound GTP (catalyzed by 
eIF5) allows the joining of the 60S subunits. Interestingly, it has been shown 
that the HCV IRES could support the reduced availability of eIF2–GTP–
tRNAiMet ternary complex that is found in stress conditions, by switching to 
an eIF2 independent mechanism when this factor is inactivated by 
phosphorylation(60). Thus, this low requirement in initiation factors certainly 
represents a selective advantage for efficient replication of HCV even under 
unfavourable physiological conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Type III IRES-mediated translation(76). initiation on type 3 IRESs involves their interaction 
with the eIF3 and 40S subunit components of 43S complexes. Type 3 IRESs directly attach 43S complexes 
to the initiation codon independently of eIF4F, eIF4B, eIF1 and eIF1A. 
 
 
The dicistroviridae family is composed of 11 members amongst whitch the 
Cricket paralysis virus (CrPV) is used like a model. The genome is organized 
in two large open reading frames, ORF1 and ORF2, that are translated as 
long polyproteins which are later processed by a virally encoded protease. 
These two ORFs are separated by an intergenic region (IGR) of 
approximately 200 nucleotides in length (Figure 16A) and are expressed by 
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two distinct IRESes. The first one lies within the 5′ UTR and was shown to 
be functional in a wide range of translational systems whereas the second 
IRES sequence is located in the intergenic region and has the unique ability 
to recruit a ribosome in the absence of initiation factors and without the 
tRNAiMet (see below). Although the length of the intergenic region varies 
among dicistroviruses, the overall secondary and tertiary structures of the 
IGR IRESes appear to be conserved. The structure can be split in three 
different domains, which all contain a pseudoknot domain (PK); PKII and 
PKIII overlap to form a stable folded domain whilst PKI is attached to them 
by a linker and forms a more independent domain 3 which is able to dock 
into the ribosome decoding groove (see Figure 16B).  
 
 
Figure 16(60). (A) Genome organization of CrPV. The first IRES is located on the 5′UTR part of the 
molecule. The first ORF ends at nucleotide 6022 when begins the intergenic region and the IGR IRES. (B) 
CrPV IGR IRES secondary structure. Domains 1, 2 and 3 are limited by coloured dashed lines. The CCU 
triplet at position 6214–6216 fits in the P site of the ribosome and determines the open reading frame used, 
the following GCU is the first codon to be translated. 
 
The CrPV IGR IRES occupies the region involved in tRNA binding in the P 
and E sites. This is mainly due to domain 3 which seems to be positioned in 
the P site and able to adopt a tRNA–mRNA conformation which mimics the 
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conformation of a tRNAiMet bound to its initiator codon. In the 80S 
ribosome the IGR IRES gets positioned in the precise hybrid state that can be 
found during the transition between a P/E hybrid tRNA and a P site tRNA. 
This P/E hybrid state could explain how the initiation can start with no 
requirement for a peptide bond formation with the amino acid loaded in the A 
site. The IGR IRESes use a unique and remarkable mechanism for translation 
as they are able to directly bind to a 40S subunit and to assemble the 80S 
ribosome without any requirement for any initiation factor, tRNAiMet or 
hydrolysis of GTP. The total absence of requirement for initiation factors 
confers to this IRES the ability to drive viral protein production in extreme 
cellular physiological conditions that can be found after induction of the 
unfolded protein response with a high level of eIF2 phosphorylation or 
following amino acid starvation. Thus, these IRESes are well adapted to the 
physiological status of the cell that is usually found during the infection by 
dicistroviruses (Figure 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Type IV IRES-mediated translation initiation(75). Initiation on type 4 IRESs involves their 
binding to 40S subunits. Type 4 IRESs initiate without eIFs or tRNAiMet. In fact the P-site of the 40S 
subunit is occupied by an IRES domain that mimics codon–anticodon base pairing. 
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Cellular-IRESs 
 
While first discovered in the RNA genomes of picornaviruses, IRES 
elements have also been identified in a subset of cellular mRNAs (Table 2).  
 
Table 2(85). Some cellular IRES elements. Some IRES elements that have been identified in cellular 
mRNAs are shown, including known cellular ITAFs that function in translation for each particular IRES. 
Note that only non-canonical ITAFs are listed; this list does not include any canonical eukaryotic translation 
initiation factors (eIFs). Apaf-1, apoptotic protease activating factor 1; XIAP, X-linked inhibitor of apoptosis 
protein; DAP5, death-associated protein 5; Bcl-2, B-cell CLL/lymphoma 2; HIAP2/c-IAP1, inhibitor of 
apoptosis protein; ODC, ornithine decarboxylase; IGF-II, insulin-like growth factor 2; VEGF, vascular 
endothelial growth factor; HIF-1α, hypoxiainducible factor 1; Cat-1, cationic amino acid transporter 1; BiP, 
immunoglobulin heavy chain-binding protein; BAG-1, BCL2-associated athanogene 1; FGF, fibroblast 
growth factor; LEF-1, lymphoid enhancer-binding factor 1. 
 
The IRESite database presents evidence of many eukaryotic cellular internal 
ribosome entry site elements and the list is growing(77). An increasing body of 
evidence indicate that these cellular IRESs have two major physiological 
functions: first they support low levels of translation initiation for cellular 
IRES-containing mRNAs with highly structured 5'-UTRs (incompatible with 
efficient scanning) under normal physiological conditions when cap-
dependent translation is fully active and second they support robust 
translation of cellular mRNAs under a variety of physiological conditions 
such as mitosis, when cap-dependent translation is compromised(63). All 
Introduction 
 
                                                                             
 28 
cellular mRNAs are presumed to be capped and should be capable of binding 
the eIF4F complex. However, it is generally believed that conventional 
scanning from the m7Gcap is not efficient for most IRES-containing cellular 
mRNAs because their 5'UTRs are typically long, GC-rich, highly structured 
and may contain several upstream translation initiation codons. It is now 
apparent that under conditions of decreased cap-dependent initiation, cellular 
IRES-mediated initiation takes over(78) like occurs for viral ones.. It has been 
demonstrated that many physiological, pathophysiological and stress 
conditions that lead to inhibition of cap-dependent translation cause a 
substantial increase in cellular IRES-mediated translation(13). Such conditions 
include, but are not limited to, endoplasmic reticulum (ER) stress, hypoxia, 
nutrient limitation, mitosis and cell differentiation. Since cap-dependent 
translation is suppressed under these conditions, it is believed that IRES-
containing mRNAs become more competitive for the available pool of 
ribosomes and translation initiation factors, including both canonical 
initiation factors and ITAFs (Figure 18). It is striking that many of the 
cellular mRNAs that contain IRES elements(77) encode proteins that are 
involved in protection of cells from stress or, alternatively, induction of 
programmed cell death (apoptosis). It should be noted, however, that in 
contrast to viral IRES elements whose mechanism of action is becoming 
better understood, very little is currently known about the mechanism 
underlying cellular IRES function. No common sequence and/or structural 
motifs have been identified to allow prediction of cellular IRES elements 
from an mRNA sequence. The vast majority of cellular IRES elements are 
located within the 5'-UTRs immediately upstream of the initiation codon. 
Nevertheless, there are cases in which the IRES is downstream of the 
initiation codon or located in the coding regions of the mRNA, thereby 
triggering synthesis of a truncated protein. Cellular IRESs, as found for viral 
IRES elements, are characterized by complex structures that often include 
stem loops and pseudoknots. These motifs can be 150-300 nucleotide long 
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even if there are cases in which 22 nucleotides long fragments are 
indicated(61).  
Similar to viral IRESs, cellular IRES elements likely participate in multiple 
interactions with components of the translational machinery (canonical 
initiation factors, ITAFs and 40S ribosomal subunits). However there have 
not been extensive systematic studies of the ability of cellular IRES elements 
to bind the 40S ribosomal subunit or of the requirements for canonical 
translation initiation factors in cellular internal initiation. It remains possible 
that certain cellular IRESs may utilize the mechanism typical for picornavirus 
IRES elements. IRESs found in c-myc, L-myc and N-myc mRNAs were 
suggested to utilize this mechanism of internal initiation(79). In addition, it has 
been postulated that some cellular IRESs, such as a short nine nt IRES from 
the mRNA of the human homeodomain protein Gtx and a 90 nucleotide 
IRES found in the human proto-oncogene IGF1R mRNA may operate 
through a Shine-Dalgarno-like interaction between the IRES and the 18S 
rRNA(80,81). Clarification of these issues is an important goal since: a large 
number of cellular IRESs have been experimentally verified(77); under stress 
conditions, 3–5% of the mRNAs are translated efficiently as determined by 
their association with polyribosomes(82); 10–15% of cellular mRNAs were 
suggested to rely on cap-independent mechanisms of translation initiation, 
independently of stress (13) and several recent reports highlight the in vivo sig-
nificance of IRES-mediated translation of specific mRNAs. 
Given the prevalence of IRES-mediated initiation under stress conditions, it 
is notable that in most cases of cellular internal initiation, the cap-binding 
protein eIF4E and the scaffolding protein eIF4G (which undergoes caspase-
mediated cleavage during stress) seem not to be required. For example, some 
studies revealed that the c-myc and N-myc IRESs do not require eIF4E or 
intact eIF4G for their activity, but do require eIF4A and eIF3(79). In this 
regard, these IRESs are similar to many viral IRES elements, such as the 
EMCV. Recently, the first case of a cellular IRES element that seem to be 
capable of direct binding to 40S ribosomal subunits was reported for the c-
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Src kinase mRNA(83). This feature of the c-Src kinase IRES element makes it 
similar to Type III and IV viral IRESs. However, it is currently unclear how 
many other cellular elements utilize the same pathway. 
The role of eIF2 has also been investigated for cellular internal initiation. 
Many cellular IRES-containing mRNAs (such as cat-1, N-myc, s-Src, etc.) 
were shown to be insensitive, or much less sensitive than mRNAs without 
IRESs, to the inhibition of protein synthesis caused by eIF2 
phosphorylation(13). Some viral IRESs (HCV), as well as some cellular IRESs 
are insensitive to this mode of translation inhibition. These observations 
suggest that different mRNAs and, in particular, different IRES-containing 
mRNAs might differ in their requirements for the active ternary complex 
and/or might utilize different pathway(s) to deliver Met-tRNAiMet to the 
ribosome. The latter pathway(s) might involve initiation factor eIF5B and/or 
Ligatin or perhaps some other proteins(63). It cannot be excluded that some 
other/additional proteins can promote Met-tRNAiMet binding to ribosomes 
in eukaryotes. To summarize, the complex nature of regulation of cellular 
mRNA translation under different pathophysiological conditions suggests 
that there may be multiple diverse pathways leading to cellular IRES-
mediated initiation. An overview of them is shown in Figure 18.   
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Figure 18. IRES-mediated mechanisms of translation initiation in eukaryotic cells(63). Cellular IRES-
mediated translation generally does not require the cap-binding protein eIF4E and/or intact eIF4G. The 
requirement for canonical initiation factors and ITAFs can vary between different IRES-containing mRNAs. 
Potential mechanisms of cellular IRES-mediated translation: (i) most, if not all, canonical initiation factors 
and many ITAFs are required; (ii) a limited number of canonical factors and ITAFs are required; and (iii) 
canonical factors are dispensable, but some ITAFs may be required.  
 
The role of ITAFs in cellular IRES-mediated translation starts to be studied. 
A striking feature of many ITAFs is that they belong to the group of 
heterogeneous nuclear ribonucleoproteins (HnRNP A1, C1/C2, I, E1/E2, K 
and L) known to shuttle between the nucleus and the cytoplasm. In addition 
to their participation in a variety of cellular activities (like RNA splicing 
and/or export), ITAFs are generally believed to be able to increase or, in 
certain cases, decrease, the affinity of binding between IRESs and 
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components of the translational apparatus (canonical initiation factors and 
ribosomes). Although the exact mechanism(s) underlying ITAF function is 
unknown it can be hypothesized that they remodel IRES spatial structures to 
produce conformations with higher or lower affinity for components of the 
translation apparatus or that they build or abolish bridges between the mRNA 
and the ribosome in addition to those provided by canonical initiation factors 
and that they take the place of canonical factors in building bridges between 
the mRNA and the ribosome. Overexpression and/or depletion of specific 
ITAFs in normal cells can affect the activity of the cellular IRESs that 
normally utilize those ITAFs without altering cap-dependent translation(84). 
Thus, it is clear that the intracellular concentration of ITAFs plays an 
important role in modulating the activity of IRESs, but the mechanism(s) 
responsible for regulating ITAF concentration have not been fully defined. 
Two alternative mechanisms have been proposed to explain the effects of 
ITAF compartmentalization. In one model, nuclear localized ITAFs were 
suggested to associate with their target IRES-containing mRNAs and 
sequester them in the nucleus away from the translational machinery. 
Alternatively, ITAFs in the nucleus were suggested to be primarily in an 
mRNA-unbound form, separated from their target IRES-containing messages 
residing in the cytoplasm. Following the appropriate signals (caused by stress 
or other physiological conditions), either the ITAF-bound mRNAs (in the 
first model) or the unbound ITAFs themselves (in the second model) were 
proposed to translocate from the nucleus to the cytoplasm, allowing 
translation of the mRNAs to proceed. Additional studies need to be done to 
better understand both the cellular IRES-mediated translation initiation steps       
and the role of ITAFs in this process.  
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IRES-mediated translation initiation in cancer 
 
As the data suggest that IRES-mediated translation occurs under conditions 
of cell stress (like exposure of cells to chemotoxic agents, apoptosis and 
hypoxia) in which cap-dependent initiation is usually inhibited and as the 
tumour cells very often live under such conditions, IRES-mediated 
translation initation is probably involved in the tumorigenesis. This 
hypothesis id enhanced even more if considered that, as shown in Table 2, 
many growth promoting and cell survival proteins  such as c-Myc, VEGF-A, 
XIAP and Apaf-1 are encoded by mRNAs that contain IRESs. For this an 
increasing attention is taken to these processes.  
Mitogenic signals such as growth factors, hormones and cytokines activate 
the protein kinase Akt (Figure 19), which in turn phosphorylates and 
activates mTOR, the kinase component of mTOR complex 1 (mTORC1). 
Activated mTOR phosphorylates and inactivates the eukaryotic 4E-BPs, 
freeing eIF4E to bind eIF4G and promoting cap-dependent translation. 
Downregulation of mTOR activity by physiological stresses such as hypoxia, 
nutrient deprivation, leads to hypophosphorylated (activated) 4E-BP proteins 
that compete with eIF4G for binding to eIF4E, preventing cap-dependent 
translation. The eIF4E/4E-BP complex might remain bound to the m7Gcap 
(as shown), possibly aiding the inhibition of cap-dependent mRNA 
translation owing to blockade of the mRNA 5′ end. Increased levels of 
hypophosphorylated 4E-BPs, in conjunction with elevated levels of eIF4G, 
can then function as a switch, impairing the initiation of translation on purely 
cap-dependent mRNAs but enhancing translation of dual mechanism mRNAs 
that also contain an internal ribosome entry site (IRES) to which eIF4G may 
bind directly. These mRNAs include vascular endothelial growth factor A 
(VEGFA), fibroblast growth factor 2 (FGF2), B-Cell Lynfoma-2(BCL2) and 
hypoxia-inducible factor 1α (HIF1A). This switch is activated by hypoxia 
and other stresses to preserve tumour cell viability and promote tumour 
angiogenesis(52). The presence of this switch is indirectly justified by the 
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identification of many mRNAs whose is induced under conditions of mTOR 
inhibition following treatment with its inhibitor rapamycin in glioblastoma 
cell lines(89). Many of these transcripts remained on actively translated 
polysomes or shifted from monosomal to polysomal translational states 
following the global inhibition of cap-dependent translation. That’s why 
those cells continue to proliferate.  
 
 
Figure 19(52). A cap-dependent to cap-independent translation switch mediated by the akt/mTOR/4E-
BP pathway. 
 
In local advanced breast cancer (LABC), the overexpression of eIF4G1 and 
4E-BP1 was shown to function as a hypoxia-activated switch in animal 
models, reducing eIF4F-dependent mRNA translation and stimulating IRES-
dependent translation. This promotes increased tumour size, angiogenesis 
and survival under hypoxic conditions through increased IRES-dependent 
translation of mRNAs encoding HIF1α, VEGFA, BCL-2 and other dual 
mechanism mRNAs that contribute to tumour growth and survival(74). It is 
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not known how overexpression of 4E-BP1 and eIF4G1 are related to 
decreased metastasis in LABC. The overexpression of eIF4G1 that is 
observed in most inflammatory breast cancers (IBCs), in the absence of 
increased levels of eIF4E and 4E-BP1, was shown to maintain high levels of 
IRES-dependent mRNA translation in animal models. Two mRNAs that are 
required for IBC survival and metastasis were identified: VEGF-A and p120 
catenin (P120CTN; also known as CTNND1)(39) which promote the 
formation of highly metastatic cancer cell clusters known as emboli. Several 
IRES-containing mRNAs clearly have important and direct roles in cancer 
development through cap-independent translation. One of the most widely 
investigated examples is that of MYC. Increased MYC expression can be 
acquired by gene amplification, increased transcription, or deregulated 
translation of its mRNA, which occurs by both cap-dependent and IRES-
dependent mechanisms. As observed for VEGF-A, HIF1α, P120CTN and 
several other IRES-containing mRNAs, the MYC IRES also uses eIF4G for 
initiation, along with several ancillary factors. It is interesting that 42% of 
patients with multiple myeloma have a C to T mutation in the MYC IRES 
sequence that results in increased cap-independent translation(86) through 
more efficient binding of the heterogeneous nuclear ribonucleoprotein K 
(HNRNPK), which is an ancillary factor for MYC IRES activity. The 
increased IRES-mediated translation of MYC mRNA in multiple myeloma 
cells is also reportedly due to interleukin-6-induced binding of another 
HNRNP (HNRNPA1) to its IRES element.  
A crucial event in tumour progression is the gain of invasive properties of 
carcinomas cells by epithelial to mesenchymal transition (EMT). This 
process is characterized by the loss of epithelial cell polarity and acquisition 
of a fibroblastoid phenotype enabling tumor cells to leave epithelial cell 
organization. EMT is induced by the IRES-mediated translation of a number 
of mRNAs, including SNAI1(88). It has been shown that in hepatocellular 
carcinoma cells (HCC) the IRES-mediated translation of some proteins such 
as Laminin B1 (LamB1) is enhanced and drives the EM transition(87). 
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Importantly in this case the IRES-mediated translation seems to be favored 
by the overexpression of some ITAFs. In fact, as just mentioned above, 
cellular IRESs generally require ITAFs for function. So, it would be expected 
that over-expression of ITAFs would enhance IRES-mediated translation, 
and it has been shown that increased expression of PTB (that is one of most 
“popular” ITAF) is associated with metastasis, and that up-regulation of YB1 
both induces epithelial–mesenchymal transition (EMT) and enhances 
metastasis(88). 
In some case, cells respond to physiological and pathophysiological stress by 
phosphorylation of the α subunit of eIF2 (as just descrived above) which 
results in an attenuation of global protein synthesis. Phosphorylation of 
eIF2α leads to reduced availability of ternary complex, and a concomitant 
decrease in global translation rates. However, translation of some mRNAs 
(such as ATF4 and GCN2) continues (or is even enhanced) under conditions 
that cause eIF2α phosphorylation since their translation is controlled by 
upstream open reading frames, a setting in which low levels of ternary 
complex promote translation of the downstream open reading frame(23). 
Continuous translation of several IRES-containing mRNAs during conditions 
of phosphorylated eIF2α and reduced ternary complex availability has also 
been reported. For example, translation of VEGF-A was substantially 
increased during tumor hypoxia, while the IRES-mediated translation of X-
chromosome linked Inhibitor of Apoptosis (XIAP) sustained during ER stress 
or was increased in response to serum starvation, low-dose gamma irradiation 
or glucose deficiency. The up-regulation of XIAP IRES-mediated translation 
enhances the survival of non-small cell lung carcinomas cells in an animal 
model(90).  It is not clear, however, how IRES-mediated translation of cellular 
mRNAs proceeds under these conditions, and what is the precise molecular 
mechanism that allows cellular IRES to function in an eIF2a -independent 
manner. A reasonable hypothesis is that the eIF2α  –dependent pathway is 
utilized for IRES-dependent translation initiation during normal growth 
conditions, whereas cellular stresses that inactivate eIF2αby phosphorylation 
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cause IRES-dependent translation to switch to an eIF5B-dependent mode(23). 
Alterations in ribosome modification have also been shown to affect IRES-
mediated translation. In patients with X-linked dyskeratosis congenita (X-
DC), the mutated DKC1 gene encodes dyskerin, a pseudouridine synthase 
that modifies ribosomal RNA. This mutation leads to a specific defect in 
IRES-mediated translation of the tumour suppressor p27 (Kip1), Bcl-XL and 
XIAP. Patients with this disorder have an increased susceptibility to cancer, 
and it is suggested that the reduced expression of p27 is partially responsible 
for this aspect of the phenotype of DKC(96). 
 
 The role of hypoxia in cancer 
Hypoxia is a reduction in the normal level of tissue oxygen tension and 
occurs during acute and chronic vascular disease, pulmonary disease and 
cancer(91). It has been estimated that 50–60% of solid tumors contain areas of 
hypoxic and/or anoxic tissues that develop as a result of an imbalance 
between oxygen supply and consumption in proliferating tumors. Low 
oxygen concentrations may result on one side from increased metabolic 
activity and oxygen consumption and, on the other side, from increased 
tumor cell distance from local capillaries and blood supply(92). Although 
hypoxia is toxic to both cancer cells and normal cells, cancer cells undergo 
genetic and adaptive changes that allow them to survive and even proliferate 
in a hypoxic environment. These processes contribute to the malignant 
phenotype and to aggressive tumour behaviour.  
Particularly, cells undergo a variety of biological responses in response to 
hypoxic conditions. The earliest recognized pathway was that hypoxic cells 
undergo a shift from aerobic to anaerobic metabolism. Hypoxia also induces 
erythropoietin (EPO) production in renal cells (to increase haemoglobin 
production) and tyrosine hydroxylase synthesis in neural cells (involved in 
catecholamine production)(91). One of the most well studied hypoxia 
responses is the production of growth factors that induce angiogenesis (new 
blood vessel formation). Many of the cellular responses to hypoxia are 
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mediated through changes in gene expression. The transcription factors 
primarily responsible for these changes are the hypoxia-inducible factors 
(HIFs). HIFs are members of the bHLH-PAS family of proteins and bind to 
canonical DNA sequences (called hypoxia regulated elements, or HREs) in 
the promoters or enhancers of target genes. They consist of an α (HIF-α) and 
a β (HIF-β, or ARNT) subunit and activate the expression of at least 150 
genes encoding proteins that regulate cell metabolism, survival, motility, 
basement membrane integrity, angiogenesis, hematopoiesis, and other 
functions (Table 3 and Figure 20). To date, two HIFs (HIF1 and HIF2) have 
been identified that regulate transcriptional programs in response to low 
oxygen levels.  
Oxygen transport and iron metabolism 
• Ceruloplasmin | erythropoietin | ferritin light chain | heme oxygenase-1 | transferrin | 
transferrin receptor 
Angiogenesis 
• Adrenomedullin | angiopoietin-2 | cyclooxygenase-2 | endothelin-1 and -2 | fibroblast growth 
factor-3 | hepatocyte growth factor | histone deacetylase | monocyte chemotactic protein-1 | 
nitric oxide synthase | osteopontin | placental growth factor | Tie-2 (an angiopoietin receptor) | 
transforming growth factor (TGF)-α, TGF-β1,TGF-β3 | vascular endothelial growth factor 
(VEGF)-A | VEGF receptor-1 
Glycolysis and glucose uptake 
• Aldolase-A | enolase-1 |glucose transporter1, 3 (GLUT1,GLUT3) | glyceraldehyde-3-
phosphate dehydrogenase| lactate dehydrogenase-A | phosfructokinase-C | phosfructokinase-L 
| phosphoglycerate kinase-1 | pyruvate kinase-M 
Transcription factors 
• Annexin V | BCL-interacting killer (BIK) | cyclin G2 | differentiated embryo-chondrocyte 
expressed gene1 (DEC1) | FOS | heat-shock factor | hypoxia-inducible factor (HIF)-1α;HIF-
2α| insulin-like growth factor (IGF) binding protein1,2, 3 | JUN | KIP1| nuclear factor-κB 
(NF-κB) | NIP3 | NIX | transgelin | transglutaminase-2 | WAF1 
Metabolism/pH/neurotransmitters 
• Acetoacetyl CoA thiolase | adenylate kinase-3 | aminopeptidase-A | carbonic anhydrase-9, -
12 | phosphoribosyl pyrophosphate synthetase | spermidine N1-acetyltransferase  
Growth factors/cytokines 
• IGF-2 | interleukin-6 | interleukin-8 | intestinal trefoil factor | macrophage inhibitory factor | 
platelet-derived growth factor-B | staniocalcin 
Stress-response pathways 
• 150-kDa ORP (oxygen-regulated protein) | growth arrest- and DNA damage-induced gene 
(GADD153) | human apurinic apyrimidinic site endonuclease (HAP-1) | thioredoxin 
Cell adhesion, extracellular matrix, cytoskeleton and proteases/coagulation 
• CD99 | collagen-5α1 | Ku70 | Ku80 | low-density lipoprotein receptor-related protein | 
metalloproteinases | matrix metalloproteinase-13 | neuronal cell-adhesion molecule L1 
(L1CAM) | plasminogen activator inhibitor-1 | tissue factor (TF) | | vimentin | α-integrin 
Table 3. Gene induced by hypoxia(91). 
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A recent survey of malignant and normal tissues found that the expression of 
both HIF-1α and HIF-2α are commonly increased in a variety of human 
tumors, including bladder, breast, colon, glial, hepatocellular, ovarian, 
pancreatic, prostate, and renal tumors(92). In clinical specimens, elevated HIF-
1 expression correlates with poor patient outcome in head and neck cancer, 
nasopharyngeal carcinoma, colorectal, pancreatic, breast, cervical, 
osteosarcoma, endometrial, ovarian, bladder, glioblastoma, and gastric 
carcinomas, while elevated HIF-2 expression correlates with poor patient 
outcome in hepatocellular, colorectal carcinoma, melanoma, ovarian, and 
non-small cell lung cancers(92).  
Figure 20. HIFs in Tumor Progression(93). Stabilization of HIF-α proteins in these cells stimulates the 
expression of numerous target genes encoding factors that mediate adaptation to hypoxic stress. Some target 
genes are regulated specifically by HIF-1α, such as those encoding the glycolytic enzymes ALDA and PGK, 
whereas others are specific targets of HIF-2α, such as those encoding TGF-α and cyclin D1. Most HIF target 
genes are regulated by both HIF-1α and HIF-2α, including those encoding the angiogenic cytokine VEGF 
and the glucose transporter GLUT1. 
 
Hypoxia mediate inhibition of general protein synthesis by the modification 
of eukaryotic translation initiation factors (eIFs) at two steps that are: 
regeneration of the “ternary complex” (eIF2-GTP and met-tRNA) and 
regulation of the m7GTP cap binding complex eIF4F (eIF4E/eIF4A/eIF4G). 
Many non-transformed cells undergo hypoxia inhibition of protein synthesis, 
whereas highly transformed cells are largely resistant(37,94,95). Although 
general translation is downregulated during hypoxia, mRNAs important for 
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adaptation to hypoxia such as HIF1α, VEGF, and platelet-derived growth 
factor (PDGF), continue to be translated. Translation in these cases is often 
cap independent due to the presence of IRES. 
Local oxygen concentrations can directly influence stem cell self-renewal 
and differentiation. One attractive hypothesis is that stem cells, particularly in 
long-lived animals, might benefit from residing in hypoxic niches where 
oxidative DNA damage may be reduced. A number of experiments over the 
past decade support the idea that cancers can grow from a discrete 
subpopulation of malignant cells with stem cell properties. These 
transformed cells are formally similar to normal stem cells in that they self 
renew and produce more committed progenitor or “transit-amplifying” cells 
whose progeny differentiate, albeit aberrantly, to produce the bulk of the 
tumor. To date, cells with these and other stem cell properties have been 
identified in human hematopoietic, brain, and breast cancers, and are likely to 
be found in other tumors(93). Consequently it’s reasonable to hypothesize that 
it’s hypoxia itself that can promote the generation of cancer stem cells 
through HIF activity. HIF activity in a rare subset of hypoxic tumor cells may 
enhance the expression or activity of other gene products including Notch, 
Oct4, c-Myc, ABC transporters (ABC-T), and telomerase to promote a stem 
cell-like state. Increased expression of KLF4, Sox2, and other factors could 
promote further dedifferentiation and confer stem cell-like properties, such as 
self-renewal, on what was originally a transformed cell with limited 
replicative potential. Inhibition of HIF activity in the resultant cancer stem 
cells might block, or reverse, this effect (Figure 21). 
The role of the translation control in cancer stem cells generation during 
hypoxia need to be studied.  
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Figure 21. Could Promote Generation of Cancer Stem Cells(93). HIF activity in a rare subset of hypoxic 
tumor cells may enhance the expression or specific gene (such as Notch, Oct4, c-Myc, ABC, KLF4, Sox2) 
to promote a stem cell-like state. 
 
Ribosome biogenesis and its association with cancer 
 
Ribosome biogenesis is a multistep highly coordinated process that led to the 
production of mature ribosomes. Briefly, all ribosomal RNAs, with the 
exception of the 5S, are transcribed as a polycistronic transcript known as 
pre- ribosomal RNA (pre-rRNA or 45S) in the nucleolus. Concomitant with 
rRNA transcription, the rRNA sequences are extensively modified. 
Specifically, a large family of small nucleolar RNAs (snoRNAs) guides the 
site-specific conversion of uridine to pseudouridine (Ψ) in rRNA. In addition, 
other snoRNAs also guide the formation of 2′-0-methylated nucleosides 
(CH3) in rRNA. The pre-rRNA precursor is then cleaved at specific sites by 
RNases to produce a series of characteristic intermediates and finally mature 
rRNAs 18S, 5.8S and 28S. During rRNA processing, the rRNA species must 
associate with more than 70 ribosomal proteins, as well as the 5S rRNA in 
the nucleolus, to form the 40S and the 60S ribosomal subunits, which are 
assembled and transported to the cytoplasm to initiate protein synthesis 
(Figure 22). Quantitative and qualitative changes in ribosome biogenesis may 
be responsible for neoplastic transformation(98)(Figure 22). Regarding the 
quantitative changes in ribosome biogenesis, there is evidence that an up-
regulation of ribosome biogenesis induces translational and post-translational 
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alterations.  Particularly the transcription of the 45S rRNA gene is negatively 
regulated by tumour suppressors such as p53 and retinoblastoma (RB) and 
augmented on mitogenic stimuli by several kinases that phosphorylate 
components of the transcription complex that are responsible for 45S 
synthesis. The accurate regulation of rRNA synthesis can be lost in cancer 
cells through inactivating mutations in tumour suppressors or upregulation of 
these kinases(97). Genome instability and reduced p53 activity might well 
explain the increased risk of cancer onset in tissues or organs in which 
hyperplastic and dysplastic lesions or chronic inflammatory processes are 
associated with ribosome biogenesis upregulation. Indeed, as ribosome 
assembly involves the association of rRNA with more than 70 ribosomal 
proteins (made in the cytoplasm), an increase in ribosomal protein production 
and activity has been observed in many cancer types(98). Mutations in 
ribosomal proteins such as S19 have also been associated with a human 
syndrome that is characterized by increased tumour susceptibility(97). 
Concerning the role of qualitative changes in ribosome biogenesis, the 
qualitative alteration of the proper functioning of the processes involved in 
ribosome biogenesis may also be responsible for a series of human diseases. 
These mainly consist of a group of rare inherited disorders in which the genes 
encoding for factors necessary for ribosome production, such as ribosomal 
protein or other factors involved in rRNA transcription and processing, are 
mutated. These disorders include X-linked dyskeratosis congenita (X-DC), 
Shwachman–Diamond Syndrome (SDS), cartilage hair hypoplasia (CHH), 
Diamond–Blackfan anemia (DBA) and Treacher Collins syndrome, and are 
jointly defined as ribosomopathies(98). Interestingly, X-DC, SDS, CHH and 
DBA are characterized by a very high incidence of cancer, supporting the 
hypothesis that specific qualitative defects in the process of ribosome 
biogenesis may also induce cancer. The mechanisms underlying increased 
cancer susceptibility in ribosomopathies are still being studied. However, it 
has been suggested that alterations in the complex structure of ribosomes, 
which are the effectors of protein synthesis, may be responsible for 
Introduction 
 
                                                                             
 43 
alterations in the translation of mRNAs of significance for neoplastic 
transformation. Such a hypothesis is gradually finding confirmatory evidence 
in X-DC, which appears to be the ribosomal disorder in which the molecular 
connections between the qualitative alterations of ribosome biogenesis and 
cancer have been better characterized and they will be discussed later in this 
thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22.  Ribosome biogenesis and the steps involved in cancer if deregulated(97). The scheme 
illustrates the main processes involved in ribosome biogenesis. The 45S precursor rRNA is site specifically 
modified (Ψ=pseudouridylation, CH3=2-O′-ribose methylation and base methylation), processed, and the 
mature 18S, 5.8S and 28S rRNA are assembled with 5S rRNA and the ribosomal proteins to form the 40Ss 
and 60Ss. Mature ribosomal subunits are exported to the cytoplasm to constitute the ribosomes. Each of the 
three blue boxes indicate the steps that could contribute to tumour initiation or cancer progression. 
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Dyskerin role in translation and cancer susceptibility  
 
X-DC is a disease characterized by a progressive failure of proliferating 
tissues (including bone marrow and skin) associated with an increased risk 
(11-fold over the control population) of developing malignancies. X-DC is 
caused by mutations in the DKC1 gene which product, dyskerin, is a 
nucleolar protein that performs at least two different major functions. First, 
dyskerin is one of the core proteins involved in small nucleolar 
ribonucleoproteic particles (snoRNPs) involved in rRNA processing. In 
particular, dyskerin is necessary for the site-specific conversion of uridine to 
pseudouridine present in the rRNA molecules. This function is necessary for 
the proper pre-rRNA maturation and involves the function of a class of small 
nucleolar RNA (snoRNA) containing a Hinge-ACA box (and therefore 
termed H/ACA snoRNA), which guides dyskerin and the other components 
of the pseudouridylation complex to specific uridine residues to be modified. 
Second, through the stabilization of the telomerase RNA component, which 
also contains an H/ACA box, dyskerin makes the proper telomerase 
enzymatic complex activity possible(99) (Figure 23).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Dyskerin in action(99). The picture shows the two major function of dyskeryn: pseudouridilation 
of the rRNA(left) and telomerase stabilitiation (right).  
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Studies in the DKC1 hypomorphic mouse model indicate that the defect in 
ribosome biogenesis plays a direct causal role in the cancer susceptibility 
observed in X-DC patients: indeed, an increase in cancer incidence is already 
observed in that model from the early generations, when telomeres are still 
very long. The observation that rRNA uridine modification is defective in the 
DKC1 hypomorphic mutant model suggested the unconventional hypothesis 
that the alteration of ribosome function might be involved in determining the 
cancer susceptibility observed in X-DC. Indeed, the uridine modification 
sites are placed within specific domains of the ribosome, which are important 
for tRNA and mRNA binding. The reduction in modified uridine residues in 
the ribosome might result in an impaired translation of specific mRNAs 
encoding for products of importance for neoplastic transformation. In line 
with this hypothesis, it has been reported that, in cells from both X-DC 
patients and DKC1 hypomorphic mice, the translation of a small sub-set of 
cellular mRNAs containing the IRES elements is inefficient.  In X-DC, the 
defect in IRES-mediated translation results in the diminished synthesis of 
protein encoded from IRES containing mRNA. This is particularly evident 
when a reduction of 5′ cap-dependent translation initiation occurs, as in the 
case of exposure to different types of stress. Initially, as translational targets 
of defective dyskerin functions, both the mRNAs encoding the anti-apoptotic 
factors Bcl-xL and XIAP and the tumor suppressor p27 were identified(100). 
In addition, the IRES containing mRNAs encoding for the tumor suppressor 
p53 have also been recently added to the list(101,102). These findings indicate 
that the mechanism responsible for the increased tumor susceptibility in X-
DC may be the defective translation of mRNAs encoding for tumor 
suppressors such as p53 and/or p27 (Figure 24). On the other hand, the defect 
in p27 mRNA translation characterizing the DKC1 hypomorphic mouse leads 
to an increase in the susceptibility to pituitary adenomas in vivo in 
association with the p27 +/− knockout background, rendering its phenotype 
at this level similar to that of the p27 −/− mouse(103). There is also evidence 
indicating that the qualitative defects in ribosome biogenesis may contribute 
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to cancer development not only in this rare inherited disorder but also in 
sporadic tumors affecting the general population. In fact the defect in the 
synthesis of p53 and p27 already described in X-DC and X-DC models has 
also been described in a sub-set of human breast carcinomas characterized by 
a strong reduction in DKC1 expression and function, and in a pituitary 
adenoma bearing a DKC1 mutation, respectively.  
Because dyskerin clearly has a role in controlling the IRES-mediated 
translation initiation and because its implications in the development, it 
should be a nice models to study the importance of alteration of the cap-
independent translation in the tumorigenesis. 
 
 
Figure 24. How qualitative defects of ribosome biogenesis may contribute to cancer(98). Simplified 
scheme summarizing the consequences of defects in dyskerin function on the translation of IRES containing 
mRNA encoding for the tumor suppressors p53 and p27. (a)When dyskerin function is maintained, the 
correctly pseudouridylated ribosomes (Ψ=pseudouridine) are able to efficiently translate these mRNAs both 
in conditions when cap-dependent translation initiation is active, and under stress conditions, including, e.g., 
genotoxic damage, hypoxia, nutrient deprivation, oncogenic stress, etc., when IRES-mediated translation 
initiation predominates. (b)Impairment of correct ribosome pseudouridylation, as in the case of dyskerin 
mutations or dyskerin-reduced expression, negatively affects cap-independent translation initiation under 
stress, resulting in reduced synthesis and accumulation of tumor suppressors and decreased cellular 
response.  
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AIM OF THE STUDY 
 
Translational control has a direct impact on cancer development and 
progression(1,52). It is now well defined that quantitative and qualitative 
changes of cap-dependent translation contribute to neoplastic transformation 
and progression. These changes may promote a global increase in protein 
synthesis to match tumour cell proliferation, and a selective translation of 
specific mRNAs that promote tumour cell survival, angiogenesis, 
transformation, invasion and metastasis(104,52). Indeed, alterations of 
eukaryotic initiation factors (such as eIF4E, eIF2α, eIF4G and eIF3) or of 
translation regulatory factors (such as 4E-BP1), as well as quantitative and 
qualitative alterations of ribosomes, and alterations of the signalling 
pathways that activate the mRNA translation (primarily the PI3K-AKT-
mTOR and Ras pathways) (4-11) are associated with cancer development and 
progression. However, the idea that “alternative” mechanisms of translation 
initiation, such as IRES-dependent translation, can be involved in the 
tumorigenesis is emerging. An example of this is X-linked dyskeratosis 
congenita (X-DC), a ribosomopathy characterized by a very high incidence 
of cancer. It has been reported that, in cells from X-DC patients, the 
translation of a small sub-set of cellular mRNAs containing the IRES 
elements is inefficient. These findings indicate that the mechanism 
responsible for the increased tumor susceptibility in X-DC may be the 
defective translation of IRES-containing mRNAs. 
Although cap-dependent translation is important during cancer progression, 
cancer cells can encounter environmental conditions that down-regulate 
mRNA cap-dependent translation. An example of such conditions is hypoxia. 
Hypoxia can be defined as a condition of sub-optimal oxygen availability to 
which cells must adapt if they want to survive. When a tumour cell is 
insufficiently supplied with oxygen, it undergoes profound modifications 
involving metabolic changes and the re-programming of gene expression at 
transcriptional and translational levels (92). In order to conserve energy, cells 
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strongly down-regulate the global translation. Nevertheless, in this condition, 
the ability of cancer cells to survive and proliferate is dependent to the 
synthesis of specific proteins required for tumor vascularization (VEGF-A), 
survival (Bcl2, survivin) and the hypoxia response (HIF1a) among other 
activities. Translation of these mRNAs occurs by IRES mediated-translation. 
(37). Little is known about the exact mechanisms by which initiation by the 
IRES occurs, or the influence of such mechanisms in angiogenesis, 
transformation, invasion and metastasis.  
Because the relevance of this kind of translation initiation in cancer 
progression is not so well clarified, the purpose of my work was to study the 
impact of IRES-dependent mRNA translation on tumourigenesis and cancer 
progression with particular regard for breast cancer. I investigated the 
consequences of the up-regulation or down-regulation of selective IRESs in 
the 5’UTR of specific mRNAs (tumour suppressor p53, growth factor VEGF-
A and response to stress hsp70) on the capability of the cells to proliferate or 
die and on the capability of cells to adhere to specific substrates. I also 
investigated the importance of changes in IRES-dependent translation in the 
acquisition of a more aggressive phenotype in immortalized but not 
transformed human epithelial cells.  
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MATERIALS AND METHODS 
 
Cells and reagents 
 
All the cells used were obtained from ATCC. Human  breast cancer derived 
cell line MCF7 and low transformed MCF10A and HMEC/TERT breast 
derived cells lines were cultured in monolayer at 37°C in humidified 
atmosphere containing 5% CO2. MCF7 were grown in RPMI 1640 
(Euroclone) supplemented with 10% of fetal bovine serum (FBS, Euroclone), 
2mM L-glutamine (Euroclone), 100 U/ mL penicillin and 100 mg/ mL 
streptomycin (Euroclone). MCF10 A and HMEC/TERT were grown in a 1:1 
mixture of Ham’s F12 and DMEM (Lonza) supplemented with 5% horse 
serum, 20 ng/ml epidermal growth factor (EGF), 100 ng/ml cholera toxin, 
0,01 mg/ml human recombinant insulin, 72,5 ng/ml hydrocortisone and 4 
µg/ml gentamycin. 
Subconfluent MCF7 cells were treated with doxorubicin 1 and 4 µM and 
deferoxamine 100 µM (Sigma-Aldrich) and collected after 72h and 96 h of 
treatment. For survival assays, cell were either  trypsinized and counted after 
trypan blue staining or formalin fixed and stained with 0.05% crystal violet  
in 20% methanol for 10 min. 
MCF10 A and HMEC/TERT were grown both in normal oxygen 
concentration and inside a hypoxia chamber at 0.5% oxygen and fed every 
two days with fresh medium. After 24h or 144h of hypoxia they were 
trypsinized and processed as described in next paragraphs. 
 
RNA interference 
 
DKC1 double stranded siRNAs and an appropriate control were obtained 
from Invitrogen: DKC1 RNAi was performed with 3 pooled siRNA 
oligonucleotides (Invitrogen catalog number HSS102781, HSS102782, 
HSS102783). siRNA were transfected in MCF7 adherent cells using  
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Lipofectamine RNAiMAX (Invitrogen) in Opti-MEM medium (Invitrogen) 
accordingly to manufacturer’s procedures. The concentrations of siRNAs 
used resulted to be capable to reduce the mRNA levels to at least the 80% of 
control for a duration of 96 h. 
 
RNA extraction and Real-time PCR 
 
Total RNA was extracted from MCF7 cells 96h after siRNA transfection 
using TRI reagent (Ambion) according to manufacturer instructions. RNA 
was reverse transcribed using the High-Capacity cDNA Archive Kit (Applied 
Biosystems) following the manufacturer instructions. Real-time PCR analysis 
was performed in a Gene Amp 7000 Sequence Detection System (Applied 
Biosystems) using the TaqMan approach. For each sample three replicates 
were analyzed. Sets of primers and fluorogenic probes specific for DKC1 
(catalog number Hs00154737_m1), p53 (Hs00153349_m1), VEGF 
(Hs00900054_m1) and b-actin (Hs99999903_m1) mRNA were purchased 
from Applied Biosystems. The relative amounts of the studied target genes 
were calculated using the expression of human β-glucuronidase (Applied 
Biosystems - 4326320E) and 18S RNA (for polysomal analysis - 
Hs99999901_s1) as an endogenous control. The final results were 
determined as follows: N target = 2-(ΔCt sample-ΔCt calibrator), where ΔCt values of 
the sample and calibrator were determined by subtracting the Ct value of the 
endogenous control gene from the Ct value of each target gene.  
 
mRNA transfection 
Capped mRNA was transcribed from linearized pR-EMCV-IRES-F (gift 
from Prof. A.C. Palmenberg), pR-HCV-IRES-F (gift from Prof R.E. Lloyd,) 
pR-CrPV-IRES-F (gift of Dr. Ruggero), pR-p53-IRES-F plasmids (gift from 
Dr. Mazumder), pR-VEGF-A -IRES-F (gift of Prof. G.J. Goodall) and pR-
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Hsp70-IRES-F (gift of Prof. I.N. Shatsky), pR-LUC (Promega) and pRL-
OCT4A-5’UTR-A using the mMessage mMachine T7 or SP6 kits (Ambion). 
Cells were transfected with 0,4µg RNA/sample using Lipofectamine 2000 
(Invitrogen) following the manufacturer instructions. After 8 hr transfection, 
cells were harvested and analyzed with dual-luciferase assay kit (Promega) 
following the manufacturer instructions.  
 
Western Blot 
 
Whole cell protein extracts and subsequent SDS-PAGE and immunoblot 
analysis were carried out according to standard procedures. Briefly, total 
cellular proteins were extracted in the lysis buffer (0.1 M KH2PO4 pH 7.5, 
1% Igepal (NP-40) added with 0.1 mM β-glycerophosphate and complete 
protease inhibitor cocktail (Roche Diagnostics) 1X). Protein concentrations 
were evaluated using Bradford assay by Biorad Protein Assay (Biorad). 
Denatured protein samples were separated in 10% SDS polyacrylamide gels 
and transferred to cellulose nitrate membranes (Hybond C Extra, Amersham). 
Filters were then saturated with 5% non fat dry milk powered dissolved in 
TBS-T solution (20 mM Tris-HCl, 137 mM NaCl pH 7.6 added with 0.1% 
Tween 20, all Sigma-Aldrich) and incubated overnight at 4°C with primary 
antibodies. The next day membranes were incubated in the presence of 
horseradish peroxidase–labeled secondary antibody (Santa Cruz 
Biotechnology, dilution 1:10.000).  The horseradish peroxidase activity was 
detected using an enhanced chemiluminescence kit ECL (GE healthcare). 
The following antibodies were used: anti-dyskerin (Santa Cruz 
Biotechnonogy,), anti-p53 (clone BP-53-12, Novocastra), anti-β-actin 
(Sigma-Aldrich), anti-eIF4G (Cell Signaling), anti-eIF4A (Cell Signaling), 
anti-eIF4E (BD-Bioscience), anti-phospho-4E-BP1 (Cell Signaling), anti-
HIF1α (BD bioscience), anti-Oct4 (Cell Signaling), anti-Sox2 (Cell 
Signalling), anti-c-Myc (Cell signalling), anti-Snail (Cell Signalling), anti-
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Slug (Cell Signalling), anti E-cadherin (Cell Signaling) and anti-fibronectin 
(Ab Cam). 
 
 
VEGF-A quantitative evaluation 
 
The quantitative evaluation of VEGF-A was made by using an enzyme-
linked immuno-assorbent assay (ELISA, Quantikine Kit, R&D) following the 
manufacturer instruction. The day before performing the assay, MCF7 
medium was changed and a less volume of the same medium was put on the 
cells in order to concentrate the protein. The day of performing the assay the 
supernatant was collected and the particulates removed by centrifugation. 
The results coming from spectrophotometer were elaborated as following 
described. Average of the duplicate readings for each standard, control, and 
sample were made and the average zero standard optical density subtracted. 
A standard curve was created by plotting the mean absorbance for each 
standard on the y-axis against the concentration on the x-axis and draw a best 
fit curve through the points on the graph. The data were linearized by plotting 
the log of the VEGF concentrations versus the log of the O.D. and the best fit 
line can be determined by regression analysis.  Samples concentration was 
determined  on the standard curve. If samples were diluted, the concentration 
read from the standard curve were multiplied by the dilution factor. Results 
are presented after relative normalization  in respect to the control. 
 
 
Analysis of protein synthesis in cells 
Protein synthesis was measured as the rate of incorporation of labelled 
leucine during a 30 minutes incubation of the subconfluent MCF7 cell 
monolayers in complete medium containing 50 mg/l leucine and trace 
amounts of [3H]leucine. Briefly after the incubation, proteins were 
precipitated with fresh 10% trichloroacetic acid. Finally the protein were 
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recovered adding 0,2 N KOH. Part of this solution was used to quantify the 
proteins and part was used to count the radioactivity. The final level of 
protein synthesis is obtained after normalize the radioactivity to the total 
amount of proteins rescue. 
  
Isolation of polyribosomal mRNA 
Subconfluent cells were harvest and pelleted. The cellular pellet was lysed in 
2 volumes of 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2 0.5% 
NP-40 for 10 minutes at 4°C. The lysates was then centrifuged at 14000 x g 
for 10 min at 4 °C and the supernatant was used for the isolation of 
polyribosomes. Lysates were stratified onto a 15-50% sucrose gradient in 30 
mM Hepes/KOH (pH 7.5), 80 mM KCl, 1.8 mM Mg-Acetate, and 
centrifuged at 4°C for 15 h at 40000 x g. From gradients, 1 ml fractions were 
collected, reading their 260 nm absorbance. Polyribosomal fractions were 
pooled and centrifuged at 10000g for 15 h at 4°C. RNA was extracted from 
pellets using the TRI reagent.  
 
Adhesion Assay 
 
Wells of a 96 well plate were coated with 0.2% gelatin or 0.01% collagen or 
20 µg/ml fibronectin ( all Sigma–Aldrich) for one hour at 37°C.  As negative 
control, some wells were left uncoated.  After washing the wells few times 
with 0.1% BSA in RPMI medium (washing buffer), wells were blocked with 
0.5% BSA in RPMI medium (blocking buffer) at 37°C for 45-60 min. In the 
mid time, MCF7 were counted and resuspended at the concentration of 
400000/ml. After washing the wells, 50 µl of cells suspension was added to 
each well and a triplicate for each samples were done. The plate was 
incubated at 37°C for 30 minutes and then rocked at 2000 rpm for 10-15 sec. 
After washing the cells were formalin fixed and stained with 0.05% crystal 
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violet in 20% methanol for 10 min. Finally the plate was read in a multiwell-
plate spectrophotometer at 450µm. The results are calculated in respect to the 
value belonged to the plastic samples.  
 
Clonogenic assay 
 
MCF10A and HMEC/TERT cells were seeded in duplicate in a 6 wells plate 
at the concentration of 250 cells/well in normal medium. The next day the 
samples were put inside the hypoxia chamber or were left inside the 
incubator at normal oxygen concentration. The cells were maintained in such 
condition for 7 days, fed with fresh medium every two day. Then they were 
fixed in methanol and stained with 0,5% crystal violet in 25% methanol for 
20 min. Finally, the colonies were counted. Results are presented as average 
of the number of colonies counted in each well for each condition. 
 
 
Colony forming assay (soft agar assay) 
 
This assay was performed in a 6 well plate in duplicate. The bottom layer 
(base agar) consisted of 2ml/well MCF10A and HMEC/TERT growing 
medium and 0.7% agarose. The base layer was left 2 hours at room 
temperature to solidify. 250000 cells were added to 1ml of the same culture 
medium contaning 0.35% agarose and plated on top of the bottom layer (top 
agar). Cells were incubated o/n at 37ºC. Next day 1 ml of culture medium 
was placed on the top of each well. Samples were cultivated in hypoxia or 
normoxia for 20 days.  Bottom medium was replaced every two days with 
fresh one. Finally the soft agar samples were washed with PBS and stained 
with 0,02% crystal violet in water for 1 hour at room temperature. The excess 
of crystal violet was washed with PBS and pictures were made. The results 
are presented as the percentage of the average of the number or colonies 
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counted in each slide dividing the colonies in accord with their size (smaller 
or bigger than 30 µm). 
 
 
Three-dimensional growth of mammary epithelial acini 
 
45 µl of growth factor reduced Matrigel (BD Bioscience) was added to each 
well of an 8 well chamber slide (BD Bioscience) on ice and spread evenly. 
The slides were placed on the cell incubator to harden fro 30-40 min. 
MCF10A and HMEC/TERT were typsinazed and counted and resuspended 
in Assay Media (same as MCF10A and HMEC/TERT growth media but with 
2%  horse serum, 5ng/ml EGF and 2% Matrigel) at a concentration of 5000 
cells/well. 400 µl of cell suspension/well was plated on top of hardened 
matrigel. Cells were grown in normoxia or hypoxia 13 days and media was 
replaced every 4 days with Assay Media. 
 
 
Immunofluorence of mammary epithelial acini 
 
During day one, cells were fixed with 2% paraformaldehyde (PFA)(Fisher 
Scientific) in PBS pH 7.4 for 20 min at RT. The cells were permeabilized 
with 0.5% Triton X-100 in PBS for no longer than 10 min at 4ºC and then 
where rinse 3 times with 100 mM glycine in PBS fro 10 min each. The cells 
were incubated with 200 µl/well of 0.2%Triton X-100, 0.1% BSA, 
0.05%Tween 20 and 10% goat serum in PBS (primary block solution) for 1 
hour at room temperature. The primary block was aspirated and the cells 
were incubated with the primary antibody in primary block solution at 4ºC 
O/N.  
During day two, chamber slides were washed three times with 0.2%Triton X-
100, 0.1% BSA, 0.05%Tween 20 in PBS (IF wash) for 20 min each. The 
cells were incubated with the secondary antibody (1:100) in IF plus 10% of 
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goat serum for 50-60 min at room temperature. The slides were kept in the 
dark until the end. The cells were rinse two times with PBS for 10 min and 
incubated with TOPRO-3 (Invitrogen) in PBS (1:200). The cells were rinse 
one with PBS and the plastic chamber where separated from the glass slide 
The slide were mounted with the Vectashield Hard-set mounting 
media+DAPI (Invitrogen) and allowed to dry at room temperature O/N in the 
dark. Slide were visualized using a confocal microscopy at 63X 
magnification.  
The following primary antibodies were used: anti-LamininV (mouse, 
Millipore), anti-α6-integrin (rabbit, Santa Cruz Biotechnologies) and anti-
GM130 (rabbit, Ab cam). The following secondary antibodies were used: 
goat FICT anti-mouse (Invitrogen) and goat TRITC anti-rabbit (Ab cam). 
 
 
Study of the secondary structure of the 5’UTR 
 
To study the structure of Oct4 and Sox2 5’UTRs, the Vienna RNAfold server 
was used. This is a free server accessible via the Vienna RNA webserver at 
http://rna.tbi.univie.ac.at/.  Input consists of a single sequence that has to be 
typed or pasted into a text field of the input form. The server predicts the 
minimum free energy (mfe) structure of a single sequence and the structure 
graph among other informations. The first 58 nucleotides of isoforms 2 of 
Oct4 mRNA sequence (NM_002701.4) and the first 438 nucleotides of Sox2 
mRNA sequence (NM_003106.3) were used. 
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Cloning 
 
The pRL-OCT4A-5’UTR-A plasmid was derived from the insertion of first 
55 mucleotides presented in the 5’UTR of Oct4 mRNA (NM_002701.4) in to 
the pRMLA vector(108) after digestion with BamHI and NcoI enzymes. The 
construct were verify by DNA sequencing. 
 
Statistical analysis. 
The Chi-square or  Mann-Whitney U tests, when appropriate, were used for 
the comparisons among groups. All statistics were obtained using the SPSS 
statistical software package (SPSS Inc., Chicago, IL). Values for p less than 
0.05 were regarded as statistically significant. 
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RESULTS 
 
Modulation of IRES-mediated translation trough DKC1 knock-
down and its consequences on the behaviour of cancer cell 
 
To study the impact of IRES-dependent mRNA translation on cancer cancer 
cells behavior, I first investigated the consequences of the modulation of 
selective IRESs present in specific mRNAs on cell proliferation, survival and 
adhesion to specific substrates.. 
To modulate or control the IRES-dependent translation I used the RNA 
interfering technique to transiently reduce DKC1 mRNA levels in a breast 
cancer cell line (MCF7). As described in the introduction of this thesis, 
DKC1 mRNA knock-down (KD) as well as DKC1 mutations, influenced the 
translation of the IRES containing XIAP, p27 and Bcl-XL mRNAs. After 
checking the effective reduction of dyskerin expression by Real time RT-
PCR and/or Western blot analyis, I evaluated the IRES-mediated activity of 
viral (EMCV, HCV and CrPV) and cellular (tumour suppressor p53, growth 
factor VEGF-A and response protein hsp70) mRNAs by using a bicistronic 
assay. Particularly the cells are transfected with a bicistronic mRNA in vitro 
transcribed in which the IRES sequence of my interest is inserted between 
the two reporter cistrons. Finally the activity of the two reporter luciferases 
(Renilla and Firefly) is evaluated. Then I estimated the capability of the 
DKC1 siRNA transfected cells to proliferate and the cell death rate. Finally I 
investigated the ability of these cells to adhere to different substrates may 
mediate metastatisazion. The results of this first part of my thesis are shown 
below. 
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DKC1 KD impairs viral IRES-mediated translation in MCF7 breast 
cancer cell line  
 
To evaluate the translation mediated by each of the four IRES types in which 
the viral IRESs have been classified, I decided to use the EMCV IRES for 
Type1 and 2, HCV IRES for Type 3 and CrPV IRES for type 4. The results 
show that strong reduction in DKC1 mRNA and dyskerin protein by transient 
RNAi in breast cancer cells MCF-7 (Figure 26,A) led to a significant 
reduction of the translation mediated by the CrPV IRES (Figure 26,B). In 
contrast, DKC1 KD doesn’t impair the translation mediated by the HCV 
(Figure 26,C) and EMCV IRESs (Figure 26,D). These results can be 
interpreted considering the different regulation on which each viral IRES 
classes can be subjected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A	   B	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Figure 26.  Dyskerin knock down impairs viral IRES translation inititation. A, dyskerin expression by 
Real-time RT-PCR and Western blot analysis in MCF-7 cells after transfection with DKC1-specific or 
control (SCR) siRNAs. B,C,D. IRES-mediated translation assessed by measuring the FLuc and RLuc 
activity in MCF-7 cells after DKC1 and control (SCR) siRNA transfection and 8 hours after transfection 
with a bicistronic mRNA transcribed from pRL CrPV-IRES (B), pRL HCV-IRES(C) and pLR EMCV-
IRES(D). siRNA transfection was performed 96 hours before cell harvesting. Histograms represent means 
and SDs from three independent experiments. P value <0,05 are considered significative. NS= not 
significant. 
 
 
DKC1 KD impairs cellular IRES-mediated translation in MCF7 breast 
cancer cell line  
 
As the rate of the viral IRESs translation initiation seems to vary accordingly 
with the viral type, I wondered if cellular IRES translation initiation can have 
a similar heterogeneous behaviour in cell within reduced DCK1 expression 
and if it is true, if this led the breast cancer cells to be committed to a more 
aggressive phenotype. To answer the questions I decided to analyze the 
IRES-mediated translation of proteins that can have important role in cancer. 
Through a research in the IRESsite database, I decided to consider the 
translation mediated by the IRESs of a tumour suppressor (p53), of a growth 
factor profoundly involved in the tumour angiogenesis (VEGF-A) and of a 
stress response protein clearly associated with loss of differentiation in breast 
cancer (Hsp70). 
DKC1 KD strongly reduced the p53-IRES-mediated translation (Figure  
27,A) but increased the VEGF(Figure 27,B) and Hsp70-IRES(Figure 27C) 
mediated translation. The results show for the first time that translational 
alteration due to reduced dyskerin levels can up or down regulate IRES-
translation initiation of specific mRNAs. As a consequence it can be 
speculated that IRES-mediated translation of mRNAs is important for cell 
proliferation, angiogenesis, etc., can drive cell to a more “aggressive” 
behavior. 
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Figure 27.  Dyskerin knock down impairs cellular IRES translation inititation. A,B,C, IRES-mediated 
translation assessed by measuring the FLuc and RLuc activity in MCF-7 cells after DKC1 and control (SCR) 
siRNA transfection and 8 hours after transfection with a bicistronic mRNA transcribed from pRL-p53-IRES 
(A), pRL- VEGF-A-IRES(B) and pRL Hsp70-IRES(C). siRNA transfection was performed 96 hours before 
cell harvesting. Histograms represent means and SDs from three independent experiments. P value <0,05 are 
considered significative. NS= not significant. 
 
 
Impairment of cellular IRES-dependent translation is combined with 
altered protein expression in humanMCF7 breast cancer cell  
 
I then investigated if the observed translational defect of p53 and VEGF-A 
mRNAs could affect p53 and VEGF-A protein levels. Measuring the levels 
of p53 by western blot, I found that DKC1 KD strongly down-regulated the 
its levels (Figure 28,A). As VEGF-A is a soluble protein that, once produced, 
is secreted, using an ELISA array I measured the level of the  VEGF-A 
protein in the supernatant of the MCF7 (Figure 28,B). DKC1 KD leads to an 
elevated increase of secretion of the protein.  
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Figure 28. Impairment of cellular IRES-dependent translation is combined with altered protein 
expression. A, representative immunoblots showing steady state p53 levels in DKC1 KD and control MCF-
7 cells; B, histogram showing the level of VEGF-A protein detected using an ELISA array. Experiments 
were performed in MCF-7 cells. siRNA transfection was performed 96 hours before cell harvesting. 
Histograms represent means and SDs from three independent experiments. P value <0,05 are considered 
significative. 
 
Protein expression is not combined with mRNAs levels 
 
Because the reduction of dyskerin levels did not cause impairment in protein 
synthesis as well as in mRNA translation (Figure 29), to clearly address the 
effect of translation on p53 and VEGF-A protein expression showed in 
Figure 28 I decided to investigate the levels of p53 and VEGF-A mRNAs in 
MCF7 with DKC1 KD and in the control both in the total mRNAs extract 
and in the polysomal fractions. Polysomes are clusters of ribosomes 
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associated with mRNAs, indicating that the mRNA is translationally active. 
It is possible to isolate the polysomal component as far as the 40S, 60S and 
80S components on the basis of their molecular weight by ultracentrifugation 
on a sucrose gradient and to extract the mRNA bounded.  
While DKC1 KD had no significant effects on global p53 mRNA levels, it 
strongly decreased the global VEGF-A mRNA levels (Figure 30,A). 
Interestingly, DKC1 KD strongly reduced the recruitment of the p53 mRNAs 
to polysomal fractions whereas the VEGF-A mRNAs levels seems to be 
recovered (Figure 30,B). As mentioned above, previous studies indicated that 
as for DKC1 mutations, DKC1 KD influence the translation of a limited list 
of cellular IRES containing mRNAs including those encoding for XIAP, Bcl-
Xl, p27(100). I selected XIAP to confirm that results in my system. From 
Figure 30 it’s clear that DKC1 KD also influenced the translation of the IRES 
containing XIAP mRNA, while it did not affect the translation of the beta-
actin house-keeping mRNA.  These results clearly demonstrate that the effect 
on the expression of two proteins important for cancer development and 
progression as p53 and VEGF-A is due to the translational control and might 
be explained by the alterations in the IRES-mediated translation. 
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Figure 29. Global protein synthesis and mRNA translation in MCF7 DKC1 KD cells. [3H]-leucine 
incorporation (A) and Renilla luciferase (Rluc) activity (B) after transfection of an in vitro transcribed 
capped mRNA  in DKC1 KD and control MCF-7 cells. siRNA transfection was performed 96 hours before 
cell harvesting. Histograms represent means and SDs from three independent experiments. p values are > 
0,05 so the differences are not significative. 
 
 
 
Figure 30. mRNA expression in MCF7 DKC1 KD cells. Total (A) and polysome-associated (B) p53, 
VEGF-A, XIAP and β-actin mRNA levels assessed by real time PCR after DKC1 KD. Representative 
polysomal profiles are shown. P value <0,05 are considered significative. 
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Contribution of the IRES-mediated translation on cancer cells behavior 
To evaluate the functional consequences of the translational impairment 
observed in the IRES-translation on the neoplastic progression, I evaluated 
the capability of DKC1 siRNA transfected MCF-7 cells to growth or to die in 
respect of their controls. Indeed I exposed the cells to different kind of 
stresses. Particularly I treated the cells with the genotoxic agent doxorubicin 
and the hypoxic mimetic agent desferoxamine (DFX) and then analyzed the 
capability of the cells to respond to these stresses in term of proliferation and 
death rate. In basal conditions, DKC1 siRNA transfected MCF-7 cells have a 
growth advantage and death resistance. Significantly, after DKC1 KD, cells 
on one side, became resistant to doxorubicin-induced death and to DFX-
mediated cell death and on the other side they acquire a growth advantage 
under doxorubicin treatment.(Figure 31,A,B,C) 
An important phase of the tumorigenesis is the capability of cancer cells to 
invade tissues, a property that drives the metastatization. The first step in this 
process is the cellular adhesion to the extracellular matrix. Consequently I 
evaluated the ability of MCF7 with DKC1 KD to adhere to substrates that are 
present in the extra cellular matrix. Particularly I selected laminin, fibronectin 
and collagene. The DKC1 KD MCF7 cells showed the capability to better 
adhere to fibronectin and collagene substrates if compared to the control cells 
(Figure31,D). 
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Figure 31. Contribution of IRES-mediated translation to malignancy. A, cell death by Trypan blue 
exclusion test under doxorubicin. B, growth after crystal violet staining analyses under doxorubicin 
treatment. C, cell death analysis under DFX treatment is also shown. D, adhesion assay performed with 
gelatin, collagene and fibronectine. Experiments were performed in MCF-7 cells. siRNA transfection was 
performed 96 hours before cell harvesting. Histograms represent means and SDs from three independent 
experiments. P<0,05 are considered significant. 
 
 
In summary the data obtained indicated that (I) DKC1 KD can up or down 
regulate the IRES-mediated translation of viral or cellular mRNA; (II) the 
impairment in the IRES-mediated translation on one side led to reduce the 
expression of proteins (such as p53 as here demonstrated or p27 as 
previously demonstrated(100)) that usually block cell proliferation and on the 
other side led to increase the expression of proteins (such as VEGF-A or 
Hsp70) that drive the cell proliferation; (III) the effect on the protein 
expression can be ascribed to an alteration in translational control; (IV) 
IRES-translation deregulation led the breast cancer cell to have a more 
aggressive phenotype especially when subjected to stresses. 
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Hypoxia impacts on the expression of the cancer stem cells 
markers through translational control 
 
As hypoxia is a condition in which mRNA cap-dependent translation is 
down-regulated and as it seems to be important in the maintenance of the 
cancer stem cells (CSC) population of a tumor and in the 
epithelial/mesenchymal transition (EMT), I focused my attention on how 
hypoxia impacts on breast tumour stem cells through translational control. 
For these studies I used a hypoxia cell growth chamber in which I could 
control oxygen levels very accurately. I used MCF10A cells, a poorly 
transformed (immortalized) early stage breast ductal carcinoma line and  
normal human mammary epithelial cells immortalized with telomerase 
(HMEC/TERT). I performed all experiments at 0.5% O2 to reproduce the low 
levels of oxygen in the tumour mass. Cells were subjected to 24 hours and 
144 hours of hypoxia. I first verified the status of the cap-dependent 
translation by immublotting and then evaluated the expression of stemness 
(Oct4, Sox2 and c-Myc) and EMT markers (Slug and Snail). Indeed I 
investigated if the cells under hypoxia conditions can acquire the capability 
to self renew and to better growth in respect of cells grown in normal oxygen 
conditions. Finally, the involvement of the IRES-mediated translation is 
evaluated.    
 
 
Hypoxia inhibits cap-dependent translation and drives the expression of 
stemness markers in low transformed cell lines  
 
I verified the expression of the major proteins involved in the translation 
initiation such as eIF4A, eIF4G, eIF4E and the expression of the eIF4E 
regulator, 4E-BP1 (Figure 32,A). The data show no differences in the 
expression of the initiation factors but demonstrate a reduction in the 
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phosphorylation state of 4E-BP1. This is in line with the principle that under 
hypoxic conditions, there is a strong downregulation of the mTOR pathway 
that results in the hypophosphorylation of the negative regulator of cap-
dependent protein synthesis, the protein 4E-BP1.  
 
 
 
Figure 32. Hypoxia inhibits cap-dependent translation and drives the expression of stemness markers 
in MCF10A and HMEC/TERT. A, rappresentative immunoblotting for the expression of the major 
proteins involved in translation initiation. B, rappresentative immunoblotting fort he expression of the three 
stemnness master factors. C, rappresentative immunoclotting of some EMT markers. Experiments were 
performed  three times in MCF10A and HMEC/TERT under normoxia (N) or hypoxia (H, 0,5% O2) for 24 
or 144h. The right loading of the gel was evaluated in respect of eIF4A expression. 
 
After I verified that the cells were really under hypoxic conditions by the 
Western Blot analysis of the induced expression/stabilization of HIF1α 
protein, I examined the expression of factors that are well established to be 
involved in the promotion of cell “stemness”, that is, stem like 
characteristics.  The three essential master factors of cell stemness 
established in literature are Oct4, Sox2 and c-Myc.  Under hypoxia in both 
MCF10A and HMEC/TERT cells, there is a significant increase in the 
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expression of Oct4, Sox2 and c-Myc, especially after 144 hours of hypoxia 
(Figure 32,B). Instead in highly transformed MDA MB-231 the expressions 
of the three masters factors is undetectable (data not shown). Since stemness 
is very often associated with EMT I examined the expression of factors that 
drive directly this mechanism (Figure 32,C).  The results obtained 
demonstrated that in weakly transformed cells under hypoxia, the EMT is 
actually blocked. 
 
 
Contribution of hypoxia to cancer cells behaviour 
 
To investigate the consequences of the up regulation of the stemness markers 
into the selection of a more aggressive subgroup of cells I first performed a 
clonogenic assay. Clonogenic assay is based on the ability of a single cell to 
grow into a colony. The assay essentially tests every cell in the population for 
its ability to undergo “unlimited” division. Only a fraction of seeded cells 
retains the capability to produce colonies. Results showed no significant 
differences in the number of colonies formed under hypoxia by the MCF10A 
cells but an increased in the number of colony formed by HMEC/TERT 
(Figure 33). This means that the HMEC/TERT has higher capability of cell 
renewal compared with MCF10A. The fact the MCF10A are much more 
transformed than HMEC/TERT could explain the non-significance observed 
in the MCF10A cells. 
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Figure 33. MCF10A and HMEC/TERT ability to self–renew is increased under hypoxia. Clonogenic 
assay of MCF10A and HMEC/TERT. A, Pictures represent the colonies formed after cultivating MCF10A 
and HMEC/TERT under normoxia (N) or hypoxia (H). B, histograms representing the number of colonies 
counted at the end of the treatment. Histograms represent means and SDs from three independent 
experiments. P<0,05 are considered significant. 
 
Compared to non-transformed cells, neoplastic cells are much less contact-
inhibited, exhibit anchorage-independent growth, and can proliferate in the 
absence of exogenous growth factors. As shown in Figure 34,A MCF10A in 
hypoxic conditions form bigger colonies. Instead for HMEC/TERT (Figure 
34,B) no differences are shown. Importantly even if there were no differences 
in the number of the colonies, the colonies growing in hypoxic conditions, 
were really bigger for both the cells lines. 
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Figure 34. The growing rate of MCF10a and HMEC/TERT is increasing under hypoxia.  Soft agar 
assay of MCF10A and HMEC/TERT.  On the left side of panel A and B representative pictures of MCF10A 
(A) and HMEC/TERT (B) cells colonies grown in a semisolid medium in normoxia (N) or hyoxia (H)  are 
reported.  The colonies were divided in two groups accordingly to their size (< 30µm and >30µm).  
Histograms (right side of each panels) represent the number of colonies counted in each groups at the end of 
the treatment. Histograms represent means and SDs from three independent experiments. P<0,05 are 
considered significant. In the bold square of each panel. the average size of the colonies is reported. 
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Finally, because cells grown as monolayers don’t recapitulate the glandular 
structure of epithelium in vivo they don’t provide a complete system to fully 
understand how proliferation, cell death and differentiation can influence the 
form and function of the glandular epithelium during the early stages of the 
tumor formation. That’s why I decided to use a three-dimensional (3D) 
culture system to investigate if hypoxia can influence these characteristics. 
The 3D culture system permits to recapitulate some features of the breast 
epithelium, including the formation of acini-like spheroids with an inner 
lumen, apicobasal polarization and basal deposition of the basement 
membrane components. Importantly transformed cells lose polarization, 
acquiring the ability to move somewhere else especially if transformed. 
Results reported in Figure 35 showed that MCF10A acinis grown in hypoxia 
are not perfect spheroids. Indeed it’s possible to see the partial lost of cells 
polarization as GM130, a Golgi marker apically located, and α6-integrin, a 
membrane marker basolaterally located, are distributed differently. The same 
results can be observed in the HMEC/TERT (Figure 36).  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Under hypoxia MCF10A lost the normal acini conformation. Three dimensional culture of 
MCF10A. Representative pictures of three dimensional culture of  three indipendent experiments of 
MCF10A cells grown in normoxia (N) or hypoxia (H). Green=laminin staining, Red=GM130 or α6-integrin 
staining as indicated, Blue=nuclei staining.  
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Figure 36. Under hypoxia HMEC/TERT lost the normal acini conformation. Three dimensional culture 
of HMEC/TERT. Representative pictures of three dimensional culture of  three indipendent experiments of 
HMEC/TERT cells grown in normoxia (N) or hypoxia (H). Green=laminin staining,  Red=GM130 or α6-
integrin staining as indicated, Blue=nuclei staining.  
 
 
 How translational control drives the phenotype in hypoxia 
 
 Another important issue is to understand whether the induction of stemness 
factors in “non transformed” cell lines is driven by alternative mechanisms of 
translation initiation. To achieve this aim, I initiated analyzing the sequence 
of the 5’UTRs in the mRNAs of Oct4 and Sox2 using a computational server 
(Vienna RNAfold) (Figure 37). I discovered that the 5’UTR of the A isoform 
of Oct4 (Oct4A), the isoform clearly implicated in stemness, is a 55 bases 
long sequence with a stem region that is very rich in C-G basepairs and 
sufficiently stable (free energy is -14,59 kcal/mol)(Figure 37,A). Sox2 
5’UTR is a 438 bases long RNA with different stable secondary structures 
(free energy is -173,18 kcal/mol)(Figure 37,B).  
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Figure 37. Secondary structures of the 5’UTRs of OCT4A (A) and Sox2 (B) mRNAs. 
 
Because the western blot analysis showed that the expression of Oct4 was 
higher then the expression of Sox2 during hypoxia, I decided to start cloning 
the Oct4 5’UTR sequence into a bicistronic mRNA translation vector to 
verify if in this system the expression of the second cistron can be driven 
under hypoxia by the 5’UTR of Oct4A.  I started with MCF10A (Figure 38). 
Unfortunately there are no differences in the expression of the second 
cistrons in normoxia and hypoxia. This doesn’t exclude the fact that 
alternative mechanisms of translation initiation can be implicated. 
Unfortunately, I could not investigate the activity of the 5’UTR of Oct4A in 
HMEC/TERT and the activity of the 5’UTR of Sox2.   
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Figure 38. Oct4A 5’ UTR has no IRES-activity. Oct4A 5’UTR translation assessed by measuring the 
FLuc and RLuc activity in MCF10A cells under normoxia or hypoxia for 24 and 144h. Histograms represent 
means and SDs from three independent experiments. The differences are not significant. 
 
 
 
Taken together, the results showed that low levels of oxygen permit the 
expression of stemness factors in cells that are only weakly transformed. 
Further studies are necessary to better understand how this can be linked to 
translational control as the 5’UTR of the Oct4 mRNA seems not to function 
as an IRES and the possible IRES activity of Sox2 5’UTR mRNA has not 
been tested yet, but this is the first demonstration of selection of cells with 
stem cell characteristics (cancer stem cells?) from a pool of less transformed 
cells under extreme hypoxia condition in which the cap-dependent translation 
is inhibited.   
 
 
 
 
 
Discussion 
 
                                                                             
 76 
 
 
 
 
 
DISCUSSION 
 
There is increasing evidence that changes in the IRES-dependent mRNA 
translation may contribute to tumourigenesis and cancer progression. 
However, the mechanisms involved are far from being clearly defined. For 
this reason the purpose of my work has been to study how changes in IRES-
dependent mRNA translation may led to cancer and facilitate tumour 
progression. To reach the aim, I modulated the IRES-dependent translation. 
This was achieved with the use of two different methodological approaches. 
The first methodological approach regarded the use of the technique of the 
RNA interfering to transiently reduce in a breast cancer cell line (MCF7), 
DKC1 mRNA levels, encoding dyskerin. Defect in dyskeryn function, results 
in a reduction of IRES-dependent translation activity.(100) Thus dyskerin 
clearly has a role in controlling the IRES-mediated translation initiation. In 
MCF7 cancer cells line, the control of IRES-mediated translation trough loss 
of dyskerin led to the decrease in the activity of the tumor suppressor p53 
that in turn facilitate cell proliferation. In the same system I observed an 
increase in VEGF-A IRES-mediated translation associated with an increased 
in protein secretion. As known, VEGF-A is an important mediator in the 
angiogenesis, the process that drives the formation of new vessels. It is worth 
noting that the expression of VEGF is very often associated with a worse 
prognosis in different kind of cancer, particularly in breast cancer(106). 
Furthermore I found that the IRES-mediated translation of Hsp70 is 
increased in the same system. Importantly, in breast carcinomas the 
expression of Hsp70 is associated with the lose of differentiation, increased 
proliferation, metastasis and worse prognosis(105). The differences shown in 
the regulation of IRES-mediated translation can be due to the ribosomes 
qualitative changes consequent to DKC1 KD. Even if an intrinsic functional 
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ribosomal defect has never been clearly demonstrated, the analysis of the 
mRNA associated with the polysomal fractions indicated that all the changes 
in proteins expression can be ascribed to the translational activity.  
It is possible to postulate that the defect in the pseudourydilation can led to 
ribosome structural modification, that in turn encourages a cap-independent 
translation initiation. Moreover, the present results did not exclude the 
possibility that the different modulation of IRES-mediated translation shown 
ca be ascribed to the different expression of the ITAFs, the “alternative” 
initiation factors mentioned in the previous sections.  
The second methodological approach used to study the involvement of the 
cap-independent translation in cancer was to modulate IRES-mediated 
translation by exposing two immortalized cell lines (MCF10A cells and 
HMEC/TERT) to hypoxia. Immortalized but not transformed cells under 
hypoxia undergo inhibition of protein synthesis, whereas highly transformed 
cells are largely resistant(37,94,95). There is evidence that in breast cancer cells, 
hypoxia activates IRES-dependent translation of mRNAs encoding HIF1α, 
VEGF-A, p120 catenin and BCL-2 (74) which are responsible for angiogenesis 
and survival. This was due to the fact that hypoxia induced the 
overexpression of eIF4G1 and 4E-BP1 whereas reduces eIF4F dependent 
translation initiation(39). In addition to the mechanism reported above by 
which hypoxia can control IRES-dependent translation, local oxygen 
concentrations can favor the tumorigenesis, influencing stem cell self-
renewal and differentiation. In this context, data reported that stem cells, 
might benefit from residing in hypoxic niches  where the oxidative DNA 
damage is reduced(93). Consequently it is reasonable to hypothesize that 
hypoxia can promote the generation of cancer stem cells trough a mechanism 
that involved IRES-dependent translation changes. For this reason I carried 
out experiments maintaining two immortalized cell lines (MCF10A and 
HMEC/TERT) at 0.5% of oxygen, a condition that is very similar to the 
oxygen concentration within the tumor mass. Hypoxia usually induced a 
great reduction of the cap-dependent translation, affecting particularly the 
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initiation phase of this process. Consequently, I verified the expression of the 
major proteins involved in the translation initiation like eIF4A, eIF4G, eIF4E 
and the expression of eIF4E’s regulator 4E-BP1. The data did not show 
differences in the expression of the initiation factors but demonstrated a 
decrease in the phosporylation state of 4E-BP1 demonstrating a reduction of 
the translation initiation in the cells. In this condition I further investigated 
the expression of the three stemness master factors, Oct4, Sox2 and c-Myc. 
In both cell lines, hypoxia induced a greater expression of all stemness 
markers. Because stemness if very often connected with the EMT, I verified 
the expression of the factors that drive the EMT, Slug and Snail and the 
expression of some epithelial markers that had to be lost during the 
epithelial-mesenchymal transition. However I did not find any changes in 
these factors in MCF10A and HMEC/TERT in hypoxic conditions. These 
results may appear to be in contrast with those reported in some papers 
showing an increased in the EMT markers expression. However those results 
were obtained analyzing mRNA and not protein expression.  
Another interesting finding was that the overexpression of the stemness 
markers in hypoxic conditions improves the capacity of breast cancer cells to 
self renewing. Using MCF10A and HMECT/TERT the number of colony 
units under hypoxia condition was higher that in the control cells. 
Furthermore, in a contest in which cap-dependent translation is reduced and 
IRES-dependent translation increased, MCFC10A and HMEC/TERT cells 
increased the ability to growth in a semisolid environment, that can be 
considered the first phase of transformation(109,110). In these experimental 
conditions, cells seeded in three dimensions and exposed to hypoxia, lose the 
polarity and seem to “escape” from the normal acinal shape.  
As reported above, hypoxia reduced the cap-dependent protein synthesis in 
MCF10A and HMEC/TERT. This is not the case for cap-independent 
translation. I consequently hypothesed that the higher expression of Oct4 and 
Sox 2 might be due to the IRES-translation activity.  Unexpectedly I found 
that the expression of Oct4 was not due to the IRES-mediated translation. 
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Two possible explanations can be suggested. The first one is the presence of 
drawbacks into the methodologies used to study the Oct4 5’UTR structure. 
The second one is that the expression of Oct4 may be due to cap-independent 
mechanisms not linked to IRES-mediated translation.  
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CONCLUSIONS 
 
 
The data obtained in this study clarify the function of cap-independent 
translation in cancer. Particularly the results suggested that the deregulation 
of IRES-dependent translation, such as characterized Dyskeratosis 
congenital,  can be considered a sort of pro-oncogenic stimulus characterized 
by the inhibition of the expression of some proteins that block cell growth 
and proliferation and by the over expression of other proteins that contributed 
to cell survival. Under stress condition, such as a hypoxic status, changes in 
IRES dependent translation in an increased ability to survive and even 
proliferate and therefore in the acquisition of a more aggressive phenotype. In 
addition in immortalized epithelial cell lines, changes in cap-independent 
translation are associated with an induction of expression of stem cell 
markers, and with the selection of a sub group of cells that have an increased 
ability to self-renewing.  
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